Skip to main content
SpringerLink
Log in

Vitamin-K-Resorptions- und Verwertungsstörungen, Hämostasedefekte bei Lebererkrankungen

  • Chapter
Blut und Blutkrankheiten

Part of the book series: Handbuch der Inneren Medizin ((INNEREN 2,volume 2 / 9))

  • 52 Accesses

Zusammenfassung

Die große Bedeutung der Gerinnungsveränderungen für die Beurteilung, Diagnose and Prognose der Lebererkrankungen ist seit langem anerkannt. Deutsch (1965) hat darauf hingewiesen, daß man bei 85% der Leberkranken mindestens einen von der Norm abweichenden Gerinnungstest findet. Dies wurde von Aoiki et al. (1977) mit 90% bestätigt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abe Y, Yoshida K, Honma K, Kawaguchi H, Murayama Y, Sakuragawa N (1980) Changes in plasma complement system in relation to the coagulation and fibrinolysis systems in obstructive jaundice. Blood Vessel 11: 305–308

    Google Scholar 

  2. Adraillou N, Yvart J, Larrieu MJ (1979) In vivo catabolism of human fibrinogen fragment D in normal subjects and patients with liver cirrhosis. Thromb Haemost 42: 189

    Google Scholar 

  3. Agnelli G, Berrettini M, Cunto M de, Nenci GG (1983) DD A VP-induced improvement of abnormal coagulation in chronic liver disease (CLD). Thromb Haemost 50: 208 (Abstr)

    Google Scholar 

  4. Ahtee L, Briley M, Raismann R, Lebrec D, Langer SZ (1981) Reduced uptake of serotonin unchanged 3H-imipramine binding in the platelets from cirrhotic patients. Life Sei 29: 2323

    CAS  Google Scholar 

  5. Alkjaersig N, Fletcher A, Burnstein R (1975) Association between oral contraceptive use and thromboembolism: A new approach to its investigation based on plasma fibrinogen chromatography. Am J Obst Gynecol 122: 199–211

    Google Scholar 

  6. Amrani DL, Plant PW, Pindyck J, Mosesson MW, Grieninger G (1983) Structural analysis of fibrinogen synthesized by cultured chicken hepatocytes in the presence or absence of dexamethasone. Biochim Biophys Acta 743: 394–400

    PubMed  CAS  Google Scholar 

  7. Ando T, Okabayashi M, Shimonaka E, Sakai M, Yoshida H, Kawade M, Takahahasi Y (1977) Utilization of hepaplastintest for diagnosis and prognosis of liver diseases. Blood Vessel 8: 51–55

    Google Scholar 

  8. Anker E, Abildgaard U, Andersen R, Fagerhol M (1983) Low antithrombin in severe disease: Consumption or decreased synthesis? Scand J Haematol [Suppl 39] 30: 59–63

    Google Scholar 

  9. Ansell JE, Kumar R, Deykin D (1977) The spectrum of vitamin K deficiency. JAMA 238: 40–42

    PubMed  CAS  Google Scholar 

  10. Aoki N (1979) a2-Plasmininhibitor. A newly discovered protease inhibitor in human plasma. In: Saldeen T (ed) The microembolism syndrom. Almquist and Wiksell International, Stockholm, pp 123–151

    Google Scholar 

  11. Aoki N, Yamanaka T (1978) The a2-plasmin inhibitor levels in liver diseases. Clin Chim Acta 84: 99–105

    PubMed  CAS  Google Scholar 

  12. Aoki T, Aoki E, Ito Y, Kano H, Ueda Y, Okado K, Okuda N (1977) Diagnostic value of coagulation test in liver disease. Blood Vessel 8: 28–32

    Google Scholar 

  13. Ardaillou N, Yvart J, Le Bras P, Larrieu MJ (1980) Catabolism of human fibrinogen fragment D in normal subjects and patients with liver cirrhosis. Thromb Haemorrh 44: 146–149

    CAS  Google Scholar 

  14. Arias IM (1982) Prothrombin and vitamin K revisited. Hepatology 2: 511

    PubMed  CAS  Google Scholar 

  15. Amman R, Gyzander E, Hedner U, Olsson R, Teger-Nilsson AC (1980) Natural protease inhibitors to fibrinolysis in liver diseases. Hepatogastroenterology 27: 254–258

    Google Scholar 

  16. Astrup T, Müllertz S (1952) The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys 40: 346–351

    PubMed  CAS  Google Scholar 

  17. Athreya B (1977) Salicylates and the liver. Arthritis Rheum 20: 529–530

    Google Scholar 

  18. Aurousseau MH, Angeli JL de, Josso F (1981) Antithrombin III versus prothrombin in liver cirrhosis. Haemostasis 10: 104–107

    PubMed  CAS  Google Scholar 

  19. Baele G (1980) Spectophotometric determination of faktor X with S–222 in anticoagulated and cirrhotic patients. In: Lijnen HR, Collen D, Verstraete M (eds) Synthetic substrates in clinical blood coagulation assays. Martinus Nijhoff, The Hague Boston London, pp 37–43

    Google Scholar 

  20. Baele G, Matthijs E, Barbier F (1977) Antihaemophilic factor A activity, F VHI-related antigen and von Willebrand faktor in hepatic cirrhosis. Acta Haemat 57: 290–297

    Google Scholar 

  21. Baele G, Heuverswyn T van, Colardyn F, Thiery M, Barbier F (1979) Chromogenic substrate assays of antithrombin III, plasminogen and antiplasmin in disseminated intravascular coagulation and in liver cirrhosis. Int Soc Haematol Europ Afric Div, 5. Meeting Hamburg, p 148

    Google Scholar 

  22. Baele G, Vos M de, Huble F, Elewaut A, Barbier F (1984) Influence of injection sclerotherapy of oesophageal varices in liver cirrhosis on the haemostatic system. Haemostasis 14: 131

    Google Scholar 

  23. Ballard HS, Marcus AJ (1976) Platelet aggregation in portal cirrhosis. Arch Intern Med 136: 316–319

    PubMed  CAS  Google Scholar 

  24. Ballard JO, Kelly GA, Kukrika MD, Sanders JC, Eyster ME (1981) Acquired dysfibrinogenemia in a hemophiliac with hepatoma: Resolution of fibrinogen dysfunction following chemotherapy. Cancer 48: 686–690

    Google Scholar 

  25. Bang NU, Tessler SS, Heidenreich RO, Marks CA, Mattler LE (1982) Effect of Moxalactam on blood coagulation and platelet function. Rev Infec Dis [Suppl 1] 4: 546–554

    CAS  Google Scholar 

  26. Barckow D, Schwigon CD, Schirop TH (1983) Blutgerinnungsstörungen bei Intensivpatienten unter Therapie mit Cephalosporinen. Intensivmed 20: 175

    Google Scholar 

  27. Barlow GH, Firestone SL, Robbins KG (1984) Characterization of the activators synthesized by human foetal liver and by three different transformed human liver cell lines. Haemostasis 14: 95 (Abstr)

    Google Scholar 

  28. Barnhart MI (1960) Cellular site for prothrombin synthesis. Am J Physiol 199: 360–366

    PubMed  CAS  Google Scholar 

  29. Barnhart MI, Ferar J, Aoki N (1963) Demonstration of Ac-Globulin in bovine hepatocytes. Fed Proc 22: 164

    Google Scholar 

  30. Barnhart MI, Cress DC, Noonan ShM, Walsh RT (1970) 10. Influence of fibrinolytic products on hepatic release and synthesis of fibrinogen. In: Brinkhous KM, Owren PA, Wright IS, Roberts HR, Hinnom S, Kiesselbach TH (eds) Fibrinogen: structure, metabolic and pathophysiologic aspects. Schattauer, Stuttgart New York, pp 143–159

    Google Scholar 

  31. Barrison IG, Knight ID, Viola L, Boots MA, Murray-Lyon IM, Mitchell TR (1981) Platelet associated immunoglobulins in chronic liver disease. Br J Haematol 48: 347–350

    PubMed  CAS  Google Scholar 

  32. Bartheis M, Wellmann W, Pries K (1982) Successful therapy with streptokinase and urokinase in a woman with Budd-Chiari syndrome. In: Mannucci PM, D’Angelo A (eds) Urokinase: basic and clinical aspects. Academic Press, London, p 163

    Google Scholar 

  33. Bauer PI, Mandl J, Machovich R, Antoni F, Garzo T, Horvath I (1982) Specific binding of thrombin-antithrombin III complex to hepatozytes. Thromb Res 28: 595–606

    PubMed  CAS  Google Scholar 

  34. Baumgarten R, Fengler JD, Bartke D, Roschlau G, May D (1981) Peliosis hepatiseine seltene Form der arzneimittelinduzierten Leberschädiugung. Dtsch Ges Wes Z Klin Med 36: 2158–2160

    Google Scholar 

  35. Beard MEJ, Hickton ChM (1982) Haemostasis in heat stroke. Br J Haematol 52: 269–274

    PubMed  CAS  Google Scholar 

  36. Bechtold H (1983) Untersuchungen zum Mechanismus der Hypoprothrombinämie bei Salicylat-Intoxikation. Intensivmed Prax 20: 175 (Abstr)

    Google Scholar 

  37. Bechtold H, Weilemann LS, Lorenz J, Andrassy K, Trenk D, Meinertz T, Jähnchen E (1984) Couma-rinähnliche Wirkung von Zephalosporinen. 90. Tgg Dtsch Ges Inn Med, Wiesbaden, S 237 (Abstr)

    Google Scholar 

  38. Beecroft LJ (1979) Chromogenic assays for the determination of prothrombin related material in rat liver fractions. Thromb Haemost 42: 451

    Google Scholar 

  39. Berr F, Engelhardt D, Paulus W, Rindfleisch GE, Witte J (1983) Peritoneovenöser Shunt nach Le Veen bei refraktärem Aszites. Internist 24: 59–63

    PubMed  CAS  Google Scholar 

  40. Bertaglia E, Delmonte P, Vertolli U, Azzurro M, Martines D (1983) Bleeding in cirrhotic patients: a precipitating factor due to intravascular coagulation or to hepatic failure? Haemostasis 13: 328–334

    PubMed  CAS  Google Scholar 

  41. Berthier A, Brissot P, Morel H, Pommereuil M (1982) Fibronectine. Anti-thrombine III et atteinte hépatique chez l’hémophile. Nouv Rev Fr Hematol 24: 117

    Google Scholar 

  42. Bertina RM, Marel-van Nieuwkoop W van der, Dubbeldam J, Boekhout-Mussert RJ, Veitkamp JJ (1980) New method for the rapid detection of vitamin K-deflciency. Clin Chim Acta 105: 93–98

    PubMed  CAS  Google Scholar 

  43. Betterle C, Trevisan A, Girolami A (1982) Factor X and pancreatic islet A cell. Blut 45: 415–416

    PubMed  CAS  Google Scholar 

  44. Bick RL (1975 a) Prothrombin complex concentrates and chronic liver disease. Thromb Diath Hae-morrh 34:873–874

    Google Scholar 

  45. Bick RL (1975 b) Prothrombin complex concentrates and chronic liver disease. Thromb Res 7:825–826

    Google Scholar 

  46. Bick RL (1982) Clinical relevance of antithrombin III. Semin Thromb Haemost VIII: 276–287

    Google Scholar 

  47. Blanchard RA, Furie BC, Kruger SF, Furie B (1981) Prothrombin and abnormal (Des-y-carboxy)-prothrombin: Assessment of plasma levels by RIA in disorders of hepatic vitamin K-dependent carboxylation. Thromb Haemost 46: 121 (Abstr)

    Google Scholar 

  48. Bohmfalk JF, Fuller GM (1980) Plasminogen is synthesized by primary cultures of rat hepatocytes. Science 209: 408–410

    PubMed  CAS  Google Scholar 

  49. Böhmig H J (1977) The coagulation disorder of orthotopic hepatic transplantation. Semin Thromb Haemost 4: 57–82

    Google Scholar 

  50. Boneu B, Sie P, Caranobe C, Cassigneul J, Pascal J (1982) Progressive Antithrombin activity and the concentration of three thrombin inhibitors in liver cirrhosis. Thromb Haemost 47: 78

    PubMed  CAS  Google Scholar 

  51. Booth NA, Anderson JA Bennet B (1983) Molecular forms of plasminogen activator in liver disease. Thromb Haemost 50: 145

    Google Scholar 

  52. Borges DR, Webster ME, Guimaraes JA, Prado JL (1981) Synthesis of prekallikrein and metabolism of plasma kallikrein by perfused rat liver. Biochem Pharmacol 30: 1065–1069

    PubMed  CAS  Google Scholar 

  53. Bouvot JL, Reiffers J, Broustet A, Parneix M (1977) Une bien curieuse carence en Vitamine K. Nouv Press Med 6: 3647

    CAS  Google Scholar 

  54. Braude S, Arias J, Hughues RD, Canalese J, Gimson AES, Williams R, Scully MF, Kakkar VV (1981) Antithrombin III infusion during fulminant hepatic failure. Thromb Haemost 46: 369

    Google Scholar 

  55. Braun B, Rückel E, Rückel A, Borner N, Pfeiffer J, Lang H (1983) Sonographische Diagnose eines Budd-Chiari-Syndroms. Dtsch Med Wochenschr 108: 700–702

    PubMed  CAS  Google Scholar 

  56. Breddin K Disc zu Havemann und Egbring Brockhaus W (1978) Erworbener Hemmkörper gegen Faktor V bei posthepatitischer Leberzirrhose. In: Breddin K (ed) Prostaglandine und Plättchenfunktion. Schattauer, Stuttgart New York, 6: 437–442

    Google Scholar 

  57. Broekmans AW, Bertina RM, Loeliger EA, Hofmann V, Klingemann RG (1983) Protein C and the development of skin necrosis during anticoagulation therapy. Thromb Haemost 49: 251

    PubMed  CAS  Google Scholar 

  58. Brommer EJP, Boks AL, Rijken DC, Verheijen JH (1984) Fast inhibitor of plasminogen activator in severe liver disease. Haemostasis 14: 111 (Abstr)

    Google Scholar 

  59. Brousse N, Solal-Celigny P, Degott C, Lebrec D (1983) Transvenous liver biopsy in blood diseases with altered coagulation. Presse Med 12: 2439–2444

    PubMed  CAS  Google Scholar 

  60. Brown RO (1982) Total parenteral nutrition induced liver dysfunction. A review. Nutr Supp Serv 2: 14–17

    Google Scholar 

  61. Bruch K (1983) Hypoprothrombinaemia and cephalosporins. Lancet 1: 535–536

    PubMed  CAS  Google Scholar 

  62. Brunner G (1982) Akutes Leberversagen-therapeutische Aspekte 1982. Fortschr Med 100: 1290–1294

    PubMed  CAS  Google Scholar 

  63. Brunswig D (1978) Veränderungen des F Vlll-assoziierten Antigens bei Leber und Nierenerkrankungen. In: Heene DL (ed) Immunologische Probleme der Blutgerinnung-von Willebrand-Jürgens-Syndrom. Schattauer, Stuttgart New York, S 157–163

    Google Scholar 

  64. Bücheler E (1980) Postpartaler akuter Leberarterienverschluß. ROFO 133: 285–289

    PubMed  Google Scholar 

  65. Büller HR, Ten Cate JW (1983) Antithrombin III infusion in patients undergoing peritoneovenous shunt operation: failure in the prevention of disseminated intravascular coagulation. Thromb Haemost 50: 48 (Abstr)

    Google Scholar 

  66. Bullock S, Bomford A, Williams R (1980) A biochemical comparison of normal human liver and hepatocellular carcinoma ferritins. Biochem J 185: 639–645

    PubMed  CAS  Google Scholar 

  67. Burke JA, Kiesel JL, Blair JD (1976) Alpha1 -antitrypsin deficiency and liver disease in children. Am J Dis Child 130: 621–629

    PubMed  CAS  Google Scholar 

  68. Bützow GH, Burkhardt A, Novak D, Becker K (1976) Obliterierende Erkrankungen der Lebervenen. Dtsch Med Wochenschr 101: 329–334

    PubMed  Google Scholar 

  69. Calne RY (1978) Transplantation of the liver. Ann Surg 188: 129–138

    PubMed  CAS  Google Scholar 

  70. Calne RY, Williams R (1976) Der jetzige Stand der Lebertransplantation. Auswertung der Erfahrung aus 50 eigenen Lebertransplantationen. Verbesserung der frühen postoperativen Überlebenszeit durch Einführen einer neuen Technik für die Gallenwegsdrainage. Internist 17: 597–604

    Google Scholar 

  71. Cameron JL, Herlong F, Sanfey H, Boitnott J, Kaufman SL, Gott VL, Maddrey WC (1983) The Budd-Chiari syndrome: treatment by mesenteric-systemic venous shunts. Ann Surg 198: 335–346

    PubMed  CAS  Google Scholar 

  72. Cano RI, Delman MR, Pitchumoni CS, Lev R, Rosenthal WS (1975) Acute fatty liver of pregnancy-complication by disseminated intravascular coagulation. JAMA 231: 159–161

    PubMed  CAS  Google Scholar 

  73. Caranobe C, Letrenne E, Sie P, Boneu B (1982) Dosage immunologique de la prothrombine et de l’antithrombine III: deux marqueurs d’insuffisance hépatique au cours des coagulopathies de consommation. Nouv Rev Fr Hématol 24: 113

    Google Scholar 

  74. Carbtree GR, Kant JA, Fornace AJ, Rauch CA, Fowlkes DA (1983) Regulation and characterization of the mRNAs for the Aa, Bß and y-chains of fibrinogen. Ann NY Acad Sei 408: 457–66

    Google Scholar 

  75. Carlisle TL, Suttie JW (1980) Vitamin K dependent carboxylase: subcellular localization of the carboxylase and enzymes involved in vitamin K metabolism in rat liver. Biochemistry 19: 1161–1167

    PubMed  CAS  Google Scholar 

  76. Carter A, Tatarsky I, Osterweil D, Tavori S (1980) Multiple acquired haemostatic defects. Case report and review of the literature. Haemostasis 9: 79–84

    Google Scholar 

  77. Castel M, Horellou MH, Conard J, Samama M (1982) Détermination immunologique de l’inhibiteur de la fibrinolyse: HRGP application clinique. Nouv Rev Fr Hematol 24: 115

    Google Scholar 

  78. Castillo R, Maragall S, Rodés J, Clemente C, Profitos J, Ordinas A (1977) Increased factor VIII complex and defective ristocetin-induced platelet aggregation in liver disease. Thromb Res 11: 899–906

    PubMed  CAS  Google Scholar 

  79. Chan V, Chan TK, Wong V, Tso SC, Todd D (1979) The determination of antithrombin III by radioimmunoassay and its clinical application. Br J Haematol 41: 563–572

    PubMed  CAS  Google Scholar 

  80. Chan V, Lai CL, Chan TK (1981) Metabolism of antithrombin III in cirrhosis and carcinoma of the liver. Clin Sei 60: 681–688

    CAS  Google Scholar 

  81. Chillar RK, Paladugu RR (1981) Hepatic vein thrombosis (acute Budd-Chiari syndrome) in acute leucemia. Am J Med Sei 282: 153–156

    CAS  Google Scholar 

  82. Chopra S, Edelstein A, Koff RS, Zimelman AP, Lacson A, Neiman RS (1978) Peliosis hepatis in hematologic disease. JAMA 240: 1153–1155

    PubMed  CAS  Google Scholar 

  83. Chouraqui JP, Bessard G, Favier M, Kolodie L, Rambaud P (1982) Hémorragie par avitaminose K chez la femme enceinte et le nouveau-né. Thérapie 37: 447–450

    PubMed  CAS  Google Scholar 

  84. Chung DW, Rixon MW, Que BG, Davie EW (1983) Cloning of fibrinogen genes and their cDNA. Ann NY Acad Sei 408: 449–456

    CAS  Google Scholar 

  85. Chung KS, Bezeaud A, Goldsmith JC, McMillan CW, Menache D, Roberts HR (1979) Congenital deficiency of blood clotting factors II, VII, IX and X. Blood 53: 776–787

    Google Scholar 

  86. Clancy CM, Glew RH (1983) Hypoprothrombinaemia and bleeding associated with cephamandole. Lancet 1: 250

    PubMed  CAS  Google Scholar 

  87. Clark RD, Gazzard BG, Lewis ML, Flute PT, Williams R (1975) Fibrinogen metabolism in acute hepatitis and active chronic hepatitis. Br J Haematol 30: 95–102

    PubMed  CAS  Google Scholar 

  88. Clauss A (1957) Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haemat 17: 237–246

    PubMed  CAS  Google Scholar 

  89. Coccheri S, Palareti G, Dalmonte PR, Poggi M, Boggian O (1979) Investigations on intravascular coagulation in liver disease: Soluble fibrin-monomer complexes in liver cirrhosis. Haemostasis 8: 8–18

    Google Scholar 

  90. Coccheri S, Mannucci PM, Palareti G, Cateano M, Poggi M, Vigano S (1981) Fibrinogen in liver cirrhosis. Lack of correlation between soluble fibrin monomer complexes and fibrinopeptide A levels. Thromb Haemost 46: 359

    Google Scholar 

  91. Coccheri S, Mannucci PM, Palareti G, Gervasoni W (1982) Significance of plasma fibrinopeptide A and high molecular weight fibrinogen in patients with liver cirrhoses. Br J Haematol 52: 503–509

    PubMed  CAS  Google Scholar 

  92. Coccheri S, Palareti G, Dalmonte PR (1984) Medical therapy in bleeding oesophageal varices. In: Tilsner V, Matthias FR (eds) Leber, Blutgerinnung und Hämostase. Editiones Roche, S 87–96

    Google Scholar 

  93. Cockburn CG, Savidge GF (1983) Dramatic enhancement of factor VIII C:Ag activity in highly purified factor VIII/vWF by liver protein and to a lesser extent by FXa, thrombin and phospholi-pases. Thromb Haemost 50: 204

    Google Scholar 

  94. Collen D, Rouvier J, Chamone DAF, Verstraete M (1978) Turnover of radiolabeled plasminogen and prothrombin in cirrhosis of the liver. Eur J Clin Invest 8: 185–188

    PubMed  CAS  Google Scholar 

  95. Colman RW, Wong PY (1977) Participation of Hageman factor dependent pathways in human disease states. Thromb Haemost 38: 751–775

    PubMed  CAS  Google Scholar 

  96. Colvin BT, Lloyd M J (1977) Severe coagulation defect due to a dietary deficiency of vitamin K. J Clin Pathol 30: 1147–1148

    PubMed  CAS  Google Scholar 

  97. Comp PC, Jacocks RM, Rubenstein C, Radcliffe R (1981) A lysine-adsorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity. J Lab Clin Med 97: 637–645

    PubMed  CAS  Google Scholar 

  98. Comp PC, Nixon RR, Esmon CT (1984) Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex. Blood 63: 15–21

    PubMed  CAS  Google Scholar 

  99. Conard J, Morisot P, Huguet C (1976) Les troubles de l’hémostase au cours des hepatectomies partielles. Etude de 20 observations. Nouv Press Med 38: 2519–2523

    Google Scholar 

  100. Cordopatri F, Boncinelli S, Marsili M, Lorenzi P, Fabbri LP, Paci P, Salvadori M, Morfini M, Cinotti S, Casparini P (1982) Effects of charcoal hemoperfusion with prostacyclin on the coagula-tion-fibrinolysis system and platelets of patients with fulminant hepatic failure-Preliminary observations. Int J Artif Organs 5: 243–247

    PubMed  CAS  Google Scholar 

  101. Cordova C, Musca A, Violi F, Alessandri C, Vezza E (1982) Improvement of some blood coagulation factors in cirrhotic patients treated with low doses of heparin. Scand J Haematol 29: 235–240

    PubMed  CAS  Google Scholar 

  102. Cordova C, Musca A, Violi F, Allesandri C, Ferro D, Piromalli A, Balsano F (1984) Prekallikrein behaviour in chronic active hepatitis and in cirrhotic patients. Haemostasis 14: 218–222

    PubMed  CAS  Google Scholar 

  103. Corrigan JJ, Jeter M, Earnest DL (1982) Prothrombin antigen and coagulant activity in patients with liver disease. JAMA 248: 1736–1739

    PubMed  CAS  Google Scholar 

  104. Cowan DH (1975) The platelet defect in alcoholism. Ann NY Acad Sei 252: 328–341

    CAS  Google Scholar 

  105. Cowan DH, Graham RC Jr (1975) Studies on the platelet defect in alcoholism. Thromb Diath Haemorrh 33: 310–327

    PubMed  CAS  Google Scholar 

  106. Crane LJ, Miller DL (1976) Synthesis and secretion of fibrinogen and albumin by isolated rat hepatocytes. Biochem Biophys Res Commun 60: 1269–1277

    Google Scholar 

  107. Crocker JFS (1982) Reye’s Syndrom. Semin Liver Dis 2: 340–352

    CAS  Google Scholar 

  108. Delaini F, Colucci M, Bellis Vitti G de, Locati D, Poggi A, Semeraro N, Donati MB (1981) Cancer cell procoagulant: A novel vitamin K-dependent activity. Thromb Res 24: 263–266

    Google Scholar 

  109. D’Elia JA, Kaldany A, Miller DG, Yoburn DC, Kaye WA (1983) Moxalactam, bleeding and renal insufficiency. JAMA 249: 1565

    Google Scholar 

  110. Denk H, Schnack H, Deutsch E (1970) Histochemischer Nachweis fibrinolytischer Aktivität in Leber-biopsien. Acta Hepato-Splenol 17: 221–228

    CAS  Google Scholar 

  111. Dettori AG, Ponari O, Civardi E, Megha A, Pini M, Poti R (1977) Impaired fibrin formation in advanced cirrhosis. Haemostasis 6: 137–148

    PubMed  CAS  Google Scholar 

  112. Deutsch E (1965) Blood Coagulation changes in liver diseases. In: Popper H, Schaffner F (eds) Progress in liver diseases, vol II. Grüne & Stratton, New York, pp 69–83

    Google Scholar 

  113. Deutsch E (1971) Klinische Anwendung der Antikoagulantien. In: Markward F (Hrsg) Anticoagulan-tien. Springer, Berlin Heidelberg New York, S 302–508

    Google Scholar 

  114. Deutsch E (1982a) Blutgerinnungsstörungen bei nicht hämatologischen Erkrankungen. In: Wilmanns W, Hartenstein R (Hrsg) Aktuelle Probleme der Hämatologie und Onkologie. Karger, Basel, S 276–289

    Google Scholar 

  115. Deutsch E (1982b) Bildungsstörungen. Verh Dtsch Ges Inn Med 88: 1330–1335

    Google Scholar 

  116. Deutsch E (1983) Blutgerinnung und Fibrinolyse. In: Deutsch E, Geyer G (Hrsg) Deutsch E, 3. Aufl.

    Google Scholar 

  117. Deutsch E, Fischer M, Frischauf H, Honetz N, Lechner K, Pesendorder F, Stych H, Weissmann A (1970) Blood coagulation changes under L-Asparaginase therapy. Recent Results Cancer Res 33: 331–341

    PubMed  CAS  Google Scholar 

  118. Deutsch E, Dragosics B, Kopsa H, Mannhalter Ch, Rainer H (1983) Prekallikrein, HMW-Kininogen and factor XII in various disease states. Thromb Res 31: 351–364

    Google Scholar 

  119. Deyl Z, Adam M (1983) Evidence for vitamin D dependent carboxylation in osteocalcin related proteins. Biochem Biophys Res Commun 113: 294–300

    PubMed  CAS  Google Scholar 

  120. Dioguardi N, Mannucci M, Blatt PM, Roberts HR (1975) Prothrombincomplex concentrate in liver disease. Lancert II: 188

    Google Scholar 

  121. Doering EJ, Savage RA, Dittmer TE (1979) Hemolysis, coagulation defects, and fulminant hepatic failure as a presentation of Wilsons disease. Am J Dis Child 133: 440–441

    PubMed  Google Scholar 

  122. Dölle W (1975) Arzneimittelbedingte Leberschäden. In: Neumayr A (ed) Aktuelle Probleme der klinischen Hepatologie. Witzstrock, Baden-Baden Brüssel, S 12–21

    Google Scholar 

  123. Dölle W (1982) Leberschädigung durch Arzneimittel. Dtsch Z VerdauStoffwechselkr 42: 237–244

    PubMed  Google Scholar 

  124. Doods WJ, Evensen StA (1974) Effect of endotoxin on the activity of coagulation factors VII, VIII and IX produced during organ perfusion. Thromb Diath Haemorrh 32: 528–537

    Google Scholar 

  125. Doody PT (1982) Disopyramide hepatotoxicity and disseminated intravascular coagulation. South Med J 75: 496–498

    PubMed  CAS  Google Scholar 

  126. Douglas JG, Forrest JAH, Prowse CV, Cash JD, Finlayson NDC (1979) Effects of lysine vasopressin and glypressin on the fibrinolytic system in cirrhosis. Gut 20: 565–567

    PubMed  CAS  Google Scholar 

  127. Dramard JM, Allouche M, Marche C, Gislon J (1983) Chronic active hepatitis and cirrhosis in a 60-year old man with alpha–1-antitrypsin deficiency. Gastroenterol Clin Biol 7: 81–85

    PubMed  CAS  Google Scholar 

  128. Dubin A, Suen ET, Delaney R, Chiu A, Johnson BC (1980) Regulation of vitamin K-dependent carboxylation. J Biol Chem 255: 344–352

    Google Scholar 

  129. Duckert F (1983a) Orale Antikoagulantien. In: Koller F, Duckert F (Hrsg) Thrombose und Embolie. Schattauer, Stuttgart New York, S 308–334

    Google Scholar 

  130. Duckert F (1983b) Analytische Methoden. In: Koller F, Duckert F (Hrsg) Thrombose und Embolie. Schattauer, Stuttgart New York, S 761–778

    Google Scholar 

  131. Duda D, Heyes H, Wenske C (1984) Antibiotika-induzierte Hämostasestörungen und Blutungsneigungen. Dtsch Med Wochenschr 109: 388–392

    PubMed  CAS  Google Scholar 

  132. Dunn GD, Hayes P, Breen KJ, Schenker S (1973) The liver in congestive heart failure: a review. Am J Med Sei 265: 174–189

    CAS  Google Scholar 

  133. Dymock IW, Tucker JS, Woolf IL, Poller L, Thomson JM (1975) Coagulation studies as a prognostic index in acute liver failure. Br J Haematol 29: 385–395

    PubMed  CAS  Google Scholar 

  134. Edmondson HA (1980) Pathology of alcoholism. Am J Clin Pathol 74: 725–742

    PubMed  CAS  Google Scholar 

  135. Egbring R, Klingemann HG, Heimburger N, Karges HE, Beule J, Seitz R, Havemann K (1981) Antithrombin III substitution in acute hepatic failure due to CC14 intoxication. Thromb Haemost 46: 373

    Google Scholar 

  136. Egbring R, Klingemann HG, Seitz R, Heimburger N, Karges HE, Havemann K (1982) Erfahrungen mit der Antithrombin HI-Substitution bei Patienten mit akutem Leberversagen nach Tetrachlor-kohlenstoff-Vergiftung. In: Loo J van de, Asbeck F (Hrsg) Hämostase, Thrombophilie und Arteriosklerose. Schattauer, Stuttgart New York, S 642–646

    Google Scholar 

  137. Egbring R, Fuchs G, Klingemann HG, Seitz R, Karges HE (1983) Therapie von Patienten mit schwerer Leberinsuffizienz mit Antithrombin III und Plasmaderivaten. Behring Institut Mitteilungen 73: 94–110

    Google Scholar 

  138. Egbring R, Fuchs G, Seitz R, Klingemann HG, Kröniger A (1983) Gerinnungsstörungen bei akutem Leberversagen und Septikämie. Gelbe Hefte 23: 8–18

    Google Scholar 

  139. Elez I, Fontcuberta J, Fabra A, Carretero F, Adan J, Marti A, Rutllant ML (1984) Fibrinolytic activity from short term culture of human hepatocytes. Haemostasis 14: 108 (Abstr)

    Google Scholar 

  140. Elmer O, Göransson G, Zoucas E (1984) Impairment of primary hemostasis and platelet function after alcohol ingestion in man. Haemostasis 14: 223–228

    PubMed  CAS  Google Scholar 

  141. Elms MJ, Bunce IH, Bundesen PG, Rylatt DB, Webber AJ, Masci PP, Whitaker AN (1983) Measurement of crosslinked fibrin degradation products.-An immunoassay using monoclonal antibodies. Thromb Haemost 50: 591–594

    PubMed  CAS  Google Scholar 

  142. Esnouf MP, Green MR, Hill HAO, Walter SJ (1979) The inhibition of the vitamin K-dependent carboxylation of glutamyl residues in prothrombin by some copper complexes. FEBS Lett 107: 146–150

    PubMed  CAS  Google Scholar 

  143. Esposito R, Almavivia M, Rinaldi E, Lalla F de (1979) Behaviour of the coagulation factors in liver coma from viral hepatitis. Boll 1st Sieroter Milan 58: 41–47

    CAS  Google Scholar 

  144. Estler CJ (1976) Pharmakologische Aspekte der durch Arzneimittel verursachten Leberschäden und-funktionsstörungen. In: Wannagat L (Hrsg) Toxische Leberschäden. Thieme, Stuttgart, S 197— 208

    Google Scholar 

  145. Evensen SA, Forde R, Opedal I, Stormorken H (1982) Acute iron intoxication with abruptly reduced levels of vitamin K-dependent coagulation factors. Scand J Haematol 29: 25–30

    PubMed  CAS  Google Scholar 

  146. Ewe K, Reinhardt P, Müller H, Ohler W (1978) Blutungsdauer nach Leberbiopsie korreliert nicht mit peripheren Gerinnungsfaktoren. Verh Dtsch Ges Inn Med 84: 1060–1062

    PubMed  Google Scholar 

  147. Fair DS, Plow EF (1983) Synthesis and excretion of the fibrinolytic components, including a2-antiplasmin, by a human hepatoma cell line. J Lab Clin Med 101: 372–384

    PubMed  CAS  Google Scholar 

  148. Fanciullaci M, Galli P, Monetti MG, Pela L, Del Bianco PL (1976) Prekallikrein and kallikrein inhibitor in liver cirrhosis and hepatitis. Adv Exp Med Biol 70: 201–208

    Google Scholar 

  149. Farman JV, Lines JG, Williams RS, Evans DB, Samuel JR, Mason SA, Ashby BS, Calne RY (1974) Liver transplantation in man. Anaesthetic and biochemical management. Anaesthesia 29: 17–32

    Google Scholar 

  150. Farthing MJG, Clark ML, Sloane JP, Powles RL, Mcelwain TJ (1982) Liver disease after bone marrow transplantation. Gut 23: 465–474

    PubMed  CAS  Google Scholar 

  151. Fasco MJ, Hildebrandt EF, Suttle JW (1982) Evidence that warfarin anticoagulant action involves two distinct reductase activities. J Biol Chem 257: 11210–11212

    PubMed  CAS  Google Scholar 

  152. Feinstein DI (1982) Diagnosis and management of disseminated intravascular coagulation: The role of heparin therapy. Blood 60: 284–287

    PubMed  CAS  Google Scholar 

  153. Feizi Ö (1972) Hereditary hemorrhagic telangiectasia presenting with portal hypertension and cirrhosis of the liver. Gastroenterology 63: 660–664

    PubMed  CAS  Google Scholar 

  154. Fischer M (1976) Therapie von Hämostasestörungen bei Lebererkrankungen: Prothrombinkomplex-Konzentrate. Z Gastroenterol 14: 650–653

    PubMed  CAS  Google Scholar 

  155. Fischer M (1983) Substitutionstherapie mit Konzentraten des Prothrombinkomplexes bei erworbenen Gerinnungsstörungen. Wien Klin Wochenschr 95: 82–85

    PubMed  CAS  Google Scholar 

  156. Fischer M (1984) Therapie von Blutungen bei hepatogener Hämostasestörung. In: Tilsner V, Matthias FR (Hrsg) Leber, Blutgerinnung und Hämostase. Editiones Roche 1984, S 53–70

    Google Scholar 

  157. Fisher CA, Schmaier AH, Addonizio VP, Colman RW (1982) Assay of prekallikrein in human plasma: comparison of amidolytic, esterolytic, coagulation and immunochemical assays. Blood 59: 963–970

    PubMed  CAS  Google Scholar 

  158. Floersheim GL, Weber O, Tschumi P, Ulbrich M (1982) Die klinische Knollenblätterpilzvergiftung (Amanita phalloides): prognostische Faktoren und therapeutische Maßnahmen. Eine Analyse anhand von 205 Fällen. Schweiz Med Wochenschr 112: 1164 — 1177

    PubMed  CAS  Google Scholar 

  159. Flute PT (1973) Fibrinogen metabolism after liver transplantation. In: Deutsch E (ed) IV Int Congr Thromb Haemat, Abstractbook. Gistel, Vienna, p 352

    Google Scholar 

  160. Flute PT, Rake MO, Williams R, Seaman MJ, Calne RY (1969) Liver Transplantation in man. IV. Haemorrhage and thrombosis. Br Med J III: 20–23

    Google Scholar 

  161. Forman WB, Barnhart MJ (1964) Cellular site for fibrinogen synthesis. JAMA 187: 128–132

    PubMed  CAS  Google Scholar 

  162. Francis JL, Armstrong DJ (1982 a) Acquired dysfibrinogenaemia in liver disease. J Clin Pathol 35: 667–672

    Google Scholar 

  163. Francis JL, Armstrong DJ (1982 b) Fibrinogen-bound sialic acid levels in the dysfibrinogenaemia of liver disease. Haemostasis 11: 215–222

    Google Scholar 

  164. Francis JL, Armstrong DJ (1983) Sialic acid and sialyltransferase in the pathogenesis of acquired dysfibrinogenaemia. In: Haverkate F, Henschen A, Nieuwenhuizen W, Straub PW (ed) Fibrinogen structure, functional aspects, metabolism, de Gruyter, Hawthorne, pp 195–205

    Google Scholar 

  165. Francis JL, Simmonds VJ, Armstrong DJ (1983) Fibrinogen bound sialic acid and liver sialic transferase activity in an experimental animal model of cirrhosis. Thromb Haemost 50: 202 (Abstr)

    Google Scholar 

  166. Franke U, Bode Ch, Dürr HK, Bode JCh (1979) Enzymausstattung von Thrombozyten bei Alkoholikern mit und ohne Thrombopenie. Verh Dtsch Ges Inn Med 85: 786–790

    CAS  Google Scholar 

  167. Freese D (1982) Intracellular cholestatic syndromes in infance. Semin Liver Dis 2: 255–270

    Google Scholar 

  168. Friedman PA, Shia MA, Gallop PM (1979) Vitamin K-dependent y-carbonhydrogen bound cleavage and non-mandatory concurrent carboxylation of peptide-bound glutaminic acid residues. Proc Natl Acad Sei USA 76: 3126–3129

    CAS  Google Scholar 

  169. Friedman PA, Mitsch WE, Silva P (1982) Localization of renal vitamin K-dependent y-glutamyl carboxylase to tubule cells. J Biol Chem 257: 11037–11040

    PubMed  CAS  Google Scholar 

  170. Friedrichs O (1983) Blutungskomplikationen des LeVeen Shunts. Med Welt 34: 754–755

    PubMed  CAS  Google Scholar 

  171. Fritsch WP, Förster H, Knieriem HJ, Rick W, Hausamen TU (1972) Laboratoriumsdiagnostik bei Fettleber. Med Welt 23: 1820–1821

    PubMed  CAS  Google Scholar 

  172. Fritsche HM, Stemberger A, Blümel G, Vogel G, Bottermann P, Fischer M (1980) Heparinisierung bei extrakorporaler Affenleberperfusion im Coma hepaticum unter kontrollierter AT-III-Substitu-tion. In: Schimpf Kl (Hrsg) Fibrinogen, Fibrin und Fibrinkleber. Schattauer, Stuttgart New York S 419–425

    Google Scholar 

  173. Fritsche HM, Sommoggy S von, Stemberger A, Fischer M, Blümel G ( 1981 a) Haemorrhagic disorders following liver cell necrosis. Pathogenetic investigations in pigs. Thromb Haemost 46: 447

    Google Scholar 

  174. Fritsche HM, Stemberger A, Sommoggy S von, Fischer M, Blümel G (1981b) Zur Pathogenese des Gerinnungsdefektes im akuten Leberversagen-experimentelle Untersuchungen. Med Welt 12: 390–392

    Google Scholar 

  175. Fritsche HM, Stemberger A, Sommoggy S von, Fischer M, Wendt P, Wriedt-Lübbe I, Schmeller ML, Neumann G, Blümel G (1981c) Untersuchungen zur Pathophysiologic und Therapie der Gerinnungsstörungen im akuten Leberversagen. In: Blümel G, Haas S (Hrsg) Mikrozirkulation und Prostaglandinstoffwechsel-Interaktion von Blutgerinnung und Fibrinolyse mit anderen proteolytischen Enzymsystemen-Neues über Fibrinogen, Fibrin und Fibrinkleber. Schattauer, Stuttgart New York, S 465–469

    Google Scholar 

  176. Fujii M, Yasunaga K, Uchino H (1980) Correlation analysis of relationships between vitamin-K-dependent clotting factors and effective hepatic blood flow, albumin and other liver function tests. Haemostasis 9: 9–14

    PubMed  CAS  Google Scholar 

  177. Fuller GM, Nickerson JM, Adams MA (1983) Translational and cotranslational events in fibrinogen synthesis. Ann NY Acad Sei 408: 440–448

    CAS  Google Scholar 

  178. Fumarola D (1979) Endotoxin and coagulopathic disorders after ascitic fluid infusion. Mayo Clin Proc 54: 815

    PubMed  CAS  Google Scholar 

  179. Furrer HU, Tönz O (1974) Die hämolytische Krise bei Morbus Wilson. Z Kinderheilk 118: 147–162

    PubMed  CAS  Google Scholar 

  180. Fürstenberg HS, Schneider B, Rothaas W (1974) Ein Beitrag über die Veränderung der Thrombozy-tenfunktion beim Verschlußikterus. Med Welt 25: 453–454

    PubMed  Google Scholar 

  181. Galambos JT (1982) Esophageal variceal hemorrhage: Diagnosis and an over view of treatment. Semin Liver Dis 2: 211–226

    PubMed  CAS  Google Scholar 

  182. Gallop PM, Lian JB, Hauschka PV (1980) Carboxylated Calciumbinding proteins and vitamin K. N Engl J Med 302: 1460–1466

    PubMed  CAS  Google Scholar 

  183. Ganrot PD, Nilehn JE (1971) Synthesis of an abnormal prothrombin in malnutrition and biliary obstruction and during dicumarol treatment. Scand J Clin Lab Invest 28: 245–249

    PubMed  CAS  Google Scholar 

  184. Gazzard BG, Clark R, Borirakchanyavat V, Williams R (1974) A controlled trial of heparin therapy in the coagulation defect of paracetamol-induced hepatic necrosis. Gut 15: 89–93

    PubMed  CAS  Google Scholar 

  185. Gazzard BG, Clark R, Flute PT, Williams R (1975 a) Factor VIII levels during the course of acute hepatitis in a haemophiliac. J Clin Pathol 28: 972–974

    Google Scholar 

  186. Gazzard BG, Henderson JM, Williams R (1975 b) The use of fresh frozen plasma or a concentrate of factor IX as replacement therapy before liver biopsy. Gut 16: 621–625

    Google Scholar 

  187. Gehrmann G, Elbers C (1970) Thrombopenisches Hyperspleniesyndrom bei splenomegaler Leberzirrhose. Dtsch Med Wochenschr 95: 1429–1432

    PubMed  CAS  Google Scholar 

  188. Ghanem J, Hershko C (1981) Veno-occlusive disease and primary hepatic vein thrombosis in Israeli Arabs. Isr J Med Sei 17: 339–347

    CAS  Google Scholar 

  189. Gibson PR, Dudley FJ, Jakobovits AW, Salem HH, Mclnnes IE (1981) Disseminated intravascular coagulation following peritoneovenous ( LeVeen) shunt. Aust NZJ Med 11: 8–12

    Google Scholar 

  190. Giddings JC, Shaw E, Tiddenhaus EJD, Bloom AL (1975) The synthesis of factor V in tissue culture and isolated organ perfusion. Thromb Diath Haemorrh 34: 321

    PubMed  CAS  Google Scholar 

  191. Gimson AES, Langley PG, Hughes RD, Canalese J, Mellon PJ, Williams R, Woods HF, Weston MJ (1980) Preliminary communications-Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure. Lancet 1: 173–175

    PubMed  CAS  Google Scholar 

  192. Giradot JM (1982) Vitamin K-dependent Carboxylase. J Biol Chem 247: 15008–15011

    Google Scholar 

  193. Girolami A, Patrassi G, Cappellato G, Quaino V (1980) An immunological study of prothrombin in liver cirrhosis. Blut 41: 61–66

    PubMed  CAS  Google Scholar 

  194. Glasgow JE, Bagdasarian A, Colman RW (1982) Functional ax protease inhibitor produced by a human hepatoma cell line. J Lab Clin Med 99: 108–117

    PubMed  CAS  Google Scholar 

  195. Gluud C, Dejgaard A, Clemmensen J (1983) Plasma fibronectin concentrations in patients with liver diseases. Scand J Clin Lab Invest 43: 533–538

    PubMed  CAS  Google Scholar 

  196. Goebel KM (1978) Akoholbedingte hämatologische Störungen. Internist 19: 110–115

    PubMed  CAS  Google Scholar 

  197. Goebel KM, Schubotz R, Schneider J, Kaffarnik H (1979) Akute alkoholtoxische Thrombozytenstö-rung. Verh Dtsch Ges Inn Med 85: 785–786

    Google Scholar 

  198. Goldsmith GH Jr, Pence RE, Ratnoff OD, Adelstein DJ, Furie B (1982) Studies on a family with combined functional deficiencies of vitamin K-dependent coagulation factors. J Clin Invest 69: 1253–1260

    PubMed  Google Scholar 

  199. Goodman LS, Gilman A (1980) The pharmacological basis of therapeuties, 6. edn MacMillan, New York Toronto London, p 1593

    Google Scholar 

  200. Goodpasture EW (1914) Fibrinolysis in chronic hepatic insufficiency. Bull John Hopk Hosp 25: 330

    CAS  Google Scholar 

  201. Goubran F, Shaker A, Ramadan M (1982) Antithrombin III in Bilharzial liver fibrosis. Haemostasis 12: 92

    Google Scholar 

  202. Graeff H, Hafter R (1982) Detection and relevance of cross-linked fibrin derivatives in blood. Semin Thromb Haemost 8: 57–68

    CAS  Google Scholar 

  203. Gralnick HR, Givelber H, Abrams E (1978) Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule. N Eng J Med 299: 221–226

    Google Scholar 

  204. Granditsch G, Pilgerstorfer HW (1971) Vergiftung mit Acenocoumarin ( Sintrom) bei einem Kind. Wien Klin Wochenschr 83: 62–63

    Google Scholar 

  205. Graninger W, Deutsch E, Schneeweiss B, Korninger S, Sertl K, Haas B (1983) An enzymimmunoassay for platelet associated IgG and its clinical value in diagnosis of thrombocytopenias. Blut 47: 180

    Google Scholar 

  206. Grant JP, Cox ChE, Kleinman LM, Maher MM, Pittman MA, Tangrea JA, Brown JH, Gross E, Brazley RM (1977) Serumhepatic enzyme and bilirubin elevations during parenteral nutrition. Surg Gynecol Obstet 145: 573–580

    PubMed  CAS  Google Scholar 

  207. Graves CB, Grabau GG, Olson RE, Munns ThW (1980) Immunochemical isolation and electrophore-tic characterization of precursor prothrombins in H–35 rat hepatoma cells. Biochemistry 19: 266–272

    PubMed  CAS  Google Scholar 

  208. Green AJ, Ratnoff OD (1974) Elevated antihemophilic factor ( AHF, factor VIII) procoagulant activity and AHF-like antigen in alcoholic cirrhosis of the liver. J Lab Clin Med 83: 189–197

    Google Scholar 

  209. Green G, Thomson JM, Dymock IW, Poller L (1976) Abnormal fibrin polymerization in liver disease. Br J Haemat 34: 427–439

    CAS  Google Scholar 

  210. Gressner AM, Wallraff P, Roebruck P, Tittor W (1981) Fibronectin and ß2-Mikroglobulin im Plasma chronisch Leberkranker und ihre Beziehung zu „zirrhoseanzeigenden“Enzymaktivitäten im Serum. Lab Med 5: 290–296

    Google Scholar 

  211. Grieninger G, Plant PW, Liang TJ, Kalb RG, Amrani D, Mosesson W, Hertzberg KM, Pindyck J (1983) Hormonal regulation of fibrinogen synthesis in cultured hepatozytes. Ann NY Acad Sei 408: 469–488

    CAS  Google Scholar 

  212. Griffin JH, Mosher DF, Zimmerman ThS, Kleiss AJ (1982) Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation. Blood 60: 261–264

    PubMed  CAS  Google Scholar 

  213. Gugler R (1979) Arzneimittelwechselwirkungen in der Therapie mit Cumarin-Derivaten. Internist 20: 238–244

    PubMed  CAS  Google Scholar 

  214. Gütgeman A, Lie TS, Käufer C, Eßer G, Schriefers KH, Paquet KJ, Siedek M (1975) Aktuelle Probleme der Lebertransplantation. Dtsch Med Wschr 100: 2047–2052

    Google Scholar 

  215. Hahn EG, Ott U, Martini GA (1981) Fibronectin and the liver. In: Berk PD, Chalmers ThC (eds) Frontiers in liver disease. Thieme Stratton, New York Stuttgart, pp 27–43

    Google Scholar 

  216. Harada T, Makisaka Y, Nishimura H, Okuda K (1978) Complete necrotization of hepatocellular carcinoma by chemotherapy and subsequent intravascular coagulation. A case report. Cancer 42: 67–73

    Google Scholar 

  217. Harenberg J, Hepp G, Schmidt-Gayk H, Zimmermann R (1980) Eine neue Methode zur Bestimmung des Fibrinopeptid A mittels Doppelantikörper. In: Schimpf Kl (Hrsg) Fibrinogen, Fibrin und Fibrinkleber. Schattauer, Stuttgart, New York, S 387–390

    Google Scholar 

  218. Harmon DC, Demirjian Z, Ellamn L, Fischer JE (1979) Disseminated intravascular coagulation with the peritoneovenous shunt. Ann Intern Med 90: 774–776

    PubMed  CAS  Google Scholar 

  219. Hartmann RC, Luther AB, Jenkins DE, Tenorio LE, Saba HI (1980) Fulminant hepatic venous thrombosis ( Budd-Chiari syndrome) in paroxysmal nocturnal hemoglobinuria-definition of a medical emergency. John Hopk Med J 146: 247–254

    Google Scholar 

  220. Haubenstock A, Schmidt P, Zazgornik J, Balcke P, Kopsa H (1983) Hypoprothrombinaemic bleeding associated with ceftriaxone. Lancet 1: 1215–1216

    PubMed  CAS  Google Scholar 

  221. Havemann K, Egbring R (1973) Leber und Blutplättchen. In: Egli H, Beeser H (Hrsg) Leber und Blutstillung, Antikoagulantien, Aggregationshemmer. Schattauer, Stuttgart New York, S 115–144

    Google Scholar 

  222. Hayek HW, Schnack H, Widhalm S (1973) D-Penicillamin-Langzeittherapie bei Morbus Wilson im Kindesalter. Veränderungen der Blutgerinnung und Auswirkungen auf das hämatopoetische System. Wien Klin Wochenschr 85: 122–125

    Google Scholar 

  223. Heck J, Gehrmann G (1973) Plättchenkinetik bei chronischem Alkoholismus. Dtsch Med Wochenschr 98: 2123–2126

    PubMed  CAS  Google Scholar 

  224. Hedner U, Henriksson P, Nilsson IM (1975) Factor XIII in a clinical material. Scand J Haematol 14: 114–119

    PubMed  CAS  Google Scholar 

  225. Heer M, Piro vino M, Altorfer A, Schmid M, Feiten A von (1983) Reversible Thrombozytopenie bei aethylischer Hepatitis: Nachweis eines immunologischen Mechanismus. 51. Jahresversamm-lung Schweiz Ges Inn Med, Luzern 1983, S 226 (Abstr)

    Google Scholar 

  226. Heimburger N, Ronneberger H, Hein B (1981) Antithrombin III (AT III) in acute liver failure (ALF): experimental data after intoxication of dog. Thromb Haemat 46: 372

    Google Scholar 

  227. Heisig S, Scharf RE, Winkelmann M, Schneider W (1983) Elevated platelet sialic acid concentration in patients with hepatic cirrhosis. Thromb Haemost 50: 138

    Google Scholar 

  228. Held H, Busse G, Meissner J (1980) Beobachtungen bei Phenprocoumon-(Marcoumar-)vergiftung. Dtsch Med Wochenschr 105: 860–863

    PubMed  CAS  Google Scholar 

  229. Helgstrand U (1981) The influence of Cimetidine on the fibrinolytic activity in the gastric mucosa in patients with duodenal ulcer. In: Davidson JF, Nilsson IM, Astedt B (eds) Progress in fibrinolysis V. Livingstone, London Melbourne New York, pp 294–295

    Google Scholar 

  230. Helgstrand U (1981) The influence of Cimetidine on the fibrinolytic activity in the gastric mucosa in patients with duodenal ulcer. In: Davidson JF, Nilsson IM, Astedt B (eds) Progress in fibrinolysis V. Livingstone, London Melbourne New York, pp 294–295

    Google Scholar 

  231. Hellgren M, Hägnevik K, Robbe H, Björk O, Blombäck M, Eklund J (1983) Severe acquired anti-thrombin III deficiency in relation to hepatic and renal insufficiency and intrauterine fetal death in late pregnancy. Gynecol Obstet Invest 16: 107–118

    PubMed  CAS  Google Scholar 

  232. Hemker HC (1977) Drugs affecting coagulation factor synthesis. In: Ogston D, Bennett B (eds) Haemostasis: Biochemistry, physiology and pathology. Wiley, London New York Sydney Toronto, pp 467–473

    Google Scholar 

  233. Hemker HC, Hamulyäk K (1984) Physiologie und Pathophysiologic in der Leber synthetisierter Gerinnungsfaktoren. In: Tilsner V, Matthias FR (Hrsg) Leber, Blutgerinnung und Hämostase. Editiones Roche 1984, S 5–15

    Google Scholar 

  234. Hemker HC, Reekers PPM (1974) Isolation and purification of proteins induced by vitamin K-absence. Thromb Diath Haemorrh Suppl 57: 83–85

    CAS  Google Scholar 

  235. Hemker HC, Velkamp JJ (1975) Prothrombin and related coagulation factors. University Press, Leiden

    Google Scholar 

  236. Hemker HC, Veitkamp JJ, Hensen A, Loeliger EA (1963) Nature of prothrombin-synthesis: prepro-thrombinaemia in vitamin K-deficiency. Nature 200: 589–590

    PubMed  CAS  Google Scholar 

  237. Henderson JM, Millikan WJ, Chipponi J, Wright L, Sones PJ, Meier L, Warren WD (1982) The incidence and natural history of thrombus in the portal vein following distal splenorenal shunt. Ann Surg 196: 1–7

    PubMed  CAS  Google Scholar 

  238. Henny ChP, Büller HR, Ten Cate JW (1981) Spontaneous liver rupture in pregnancy associated with severe DIC: Management of the coagulation disorder prior to surgery. Thromb Haemost 46: 396

    Google Scholar 

  239. Hiebert L (1981) The uptake of heparin by liver simusoidal cells in normal and atherosclerotic rabbits. Thromb Res 21: 383–390

    PubMed  CAS  Google Scholar 

  240. Higuchi A, Sakurada K, Miyazaki T (1981a) Studies on abnormal fibrinogen in several hepatic diseases. Blood Vessel 12: 61–64

    Google Scholar 

  241. Higuchi A, Sakurada K, Miyazaki T, Suzuki J (1981b) Studies on abnormal fibrinogen in umbilical cord blood: comparison with fibrinogen of hepatoma and umbilical cord blood. Blood Vessel 12: 267–270

    Google Scholar 

  242. Higuchi A, Sakurada K, Miyazaki T (1982) Abnormal fibrinogenemia in severe hepatic diseases (the fourth report)-Studies on asialofibrinogen derived from fibrinogen in them. Blood Vessel 13: 198–201

    Google Scholar 

  243. Hiller E, Hegemann F, Possinger K (1981 a) Hypercoagulability in acute esophageal variceal bleeding. Thromb Res 22: 243–251

    Google Scholar 

  244. Hiller E, Hegemann F, Riess H (1981b) Hypercoagulability in acute esophageal variceal bleeding. Thromb Haemost 46: 367

    Google Scholar 

  245. Hillman RS (1975) Alcohol and hematopoesis. Ann NY Acad Sei 252: 297–306

    CAS  Google Scholar 

  246. Hirakawa H, Ohta W, Shimada Y (1978) Clinical studies of hemorrhagic diathesis in liver disease. Blood Vessel 9: 174–178

    Google Scholar 

  247. Högstorp H, Saldeen T (1982 a) Rat hepatocytes synthesize alpha2-antiplasmin. Haemostasis 11 [Suppl 1] 46

    Google Scholar 

  248. Högstorp H, Saldeen T (1982b) Synthesis of a2-antiplasmin by rat liver cells. Thromb Res 28: 19–26

    PubMed  Google Scholar 

  249. Högstorp H, Jacobsson H, Saldeen T (1980) Effect of hepatectomy on the posttraumatic fibrinolysis inhibition and the primary fibrinolysis inhibitor in the rat. Thromb Res 18: 361–368

    PubMed  Google Scholar 

  250. Holmberg L, Mannucci PM, Turesson I, Ruggeri ZM, Nilsson IM (1974) Factor VHI-antigen in the vessel walls in von Willebrand’s disease and haemophilia A. Scand J Haematol 13: 33–38

    PubMed  CAS  Google Scholar 

  251. Honegger H, Anderson N, Hewitt LA, Tullis JL (1981) Antithrombin III profiles in malignancy, relationship to primary tumors and metastatic sites. Thromb Haemat 46: 500–503

    CAS  Google Scholar 

  252. Hood JM, Koep LJ, Peters RL, Schröter GPH, Weil R, Redeker AG, Starzl ThE (1980) Liver transplantation for advanced liver disease with alphat-antitrypsin deficiency. N Engl J Med 302: 272–275

    PubMed  CAS  Google Scholar 

  253. Hooper A, Haney BB, Stone HH (1980) Gastrointestinal bleeding due to vitamin K deficiency in patients on parenteral cefamandole. Lancet 1: 39–40

    PubMed  CAS  Google Scholar 

  254. Hope PL, Hall MA, Millward-Sadler GH, Normand IC (1982) oct-antitrypsin deficiency presenting as a bleeding diathesis in the newborn. Arch Dis Child 57: 68–70

    Google Scholar 

  255. Hosoi A, Suzuki T, Kato T (1977) Studies on coagulation and fibrinolysis of liver disease. Blood Vessel 8: 95–98

    Google Scholar 

  256. Houghton AN, Shafi N, Rickles FR (1979) Acute hepatic vein thrombosis occurring during therapy for Hodgkins disease-Case report. Cancer 44: 2324–2329

    PubMed  CAS  Google Scholar 

  257. Howland WS, Castro EB, Fortner JB, Gould P (1974) Hypercoagulability: Thrombelastographic monitoring during extensive hepatic surgery. Arch Surg 108: 605–608

    Google Scholar 

  258. Hruby K, Thaler E, Lenz K (1981) Toxische Leberschädigung und Blutgerinnung. Ergebn Exp Med 38: 43–55

    Google Scholar 

  259. Hruby K, Fuhrmann M, Csomos G, Thaler H (1983) Pharmakotherapie der Knollenblätterpilzvergiftung mit Silibinin. Wien Klin Wochenschr 95: 225–231

    PubMed  CAS  Google Scholar 

  260. Hrynyschyn K, Kremer B (1984) Operative Eingriffe an der Leber. XXVII. Symp Blutgerinnung, Hamburg 1984

    Google Scholar 

  261. Hrynyschyn K, Schumpelick V, Koch W (1983) Erfahrungen mit dem peritoneo-venösen Shunt. Z Gastroenterol 21: 462

    Google Scholar 

  262. Hughes RD, Lane DA, Cella G, Clark SE, Kakkar VV, Ton HY, Langley PG, Williams R (1979) Heparin and platelet during haemoperfusion of patients with acute liver disease. Thromb Haemost 42: 133

    Google Scholar 

  263. Hunt DR, Allison MEM, Prentice CRM, Blumgart LH (1982) Endotoxinemia, disturbance of coagulation, and obstructive jaundice. Am J Surg 144: 325–329

    PubMed  CAS  Google Scholar 

  264. Hutchinson DR, Smith MG, Parke DV (1980) Prealbumin as an index of liver function after acute paracetamol poisoning. Lancet II: 121–123

    Google Scholar 

  265. Ideo G, Ninno E del, Bitto T, Mannucci PM (1973) Gilbert’s syndrome and coagulation factors synthetized by the liver. Rendiconti di Gastroenterologia 5: 51

    Google Scholar 

  266. Iizuka A, Satoh Ch, Nagao T (1980) Study of two-dimensional immunoelectrophoresis of prothrombin in a 6 months old patient with secondary vitamin K deficiency and thirty seven infants aged one month. Blood Vessel 11: 568–572

    Google Scholar 

  267. Isenberg JN (1982) Cystic fibrosis: Its influence on the liver, biliary tree and bile salt metabolism. Semin Liver Dis 2: 302–313

    PubMed  CAS  Google Scholar 

  268. Iwabuchi S, Mizuguchi A, Okabe K (1981) Clinical significance of antithrombin III activity in liver disease. Blood Vessel 12: 412–414

    Google Scholar 

  269. Jaffe EA (1982) Synthesis of factor VIII by endothelial cells. Ann NY Acad Sei 401: 163–170

    CAS  Google Scholar 

  270. Jaffe EA, Hoyer LW, Nachman RL (1973) Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest 52: 2757–2764

    PubMed  CAS  Google Scholar 

  271. Jedrychowski A (1974) The role of the liver in mechanisms regulating fibrinolytic activity. Klin Gastroenterol IMW/Folia Med Cracov 16: 151–192

    CAS  Google Scholar 

  272. Jester HG, Witzke G, Weyrauch D (1983) Fibrinolytische Therapie beim Budd-Chiari-Syndrom. In: Trübestein G, Etzel F (Hrsg) Fibrinolytische Therapie. Schattauer, Stuttgart New York, S 265–272

    Google Scholar 

  273. Johnson CA, Chung KS, McGrath KM, Bean PE, Roberts HR (1980) Characterization of a variant prothrombin in a patient congenitally deficient in factor II, VII, IX, X. Br J Haematol 44: 461–469

    Google Scholar 

  274. Johnston MFM, Vargo J, Joist JH (1981) Isolation and characterization of procoagulant substances from human ascites. Thromb Haemost 46: 353 (Abstr)

    Google Scholar 

  275. Juhan-Vague I, Rijken DC, Collen D (1982) Extrinsic plasminogen activator levels in clinical plasma samples. Haemostasis 11 [Suppl 1] 11

    Google Scholar 

  276. Kamiya T, Ogata K, Ueda R, Ishiguro J, Koie K, Masuko K (1977) AHF activity and AHF-like antigen in liver diseases. Blood Vessel 8: 83–88

    Google Scholar 

  277. Kanayama M, Suzuki S, Matsui N (1979) Plasma high molecular weight fibrinogen complexes in patients with various liver diseases. Blood Vessel 10: 657–660

    Google Scholar 

  278. Kanazawa T, Sato T (1977) The patterns of fibrinolytic activity in liver diseases. Blood Vessel 8: 150–155

    Google Scholar 

  279. Karitzky D, Lesch R, Goedde HW, Witt I, Boehm R, Jobke A, Künzer W (1978) Hepatopathie bei homozygotem α1-Antitrypsin-Mangel. Dtsch Med Wochenschr 103: 161–166

    PubMed  CAS  Google Scholar 

  280. Kashiwabara T, Kaito I, Sato S, Nakazawa K, Yamashina A, Suzuki K, Ikeda T, Tanaka S, Yoshida T (1980) Significance of the changes of blood FDP in fulminant hepatitis. Blood Vessel 11: 285–290

    CAS  Google Scholar 

  281. Kaulla KN von, Kaulla E von, Wasantapruek S (1979) Rapid increase of fibrinolytic activity in pig and rat after exlcusion of the liver from the circulation and its control by various organs. Acta Hepato-Gastroent 26: 4–8

    Google Scholar 

  282. Kawabe H, Nara H, Chiba Y (1977) Studies on hepaplastintest in hepatobiliary diseases. Blood Vessel 8: 326–330

    Google Scholar 

  283. Keith DA, Gallop PM (1979) Phenytoin, skeletal defects and vitamin K in the newborn. Med Hypotheses 5: 1347–1351

    PubMed  CAS  Google Scholar 

  284. Keith DA, Gundberg CM, Gallop PM (1980) Phenytoin therapy and hemorrhagic disease. J Pediatr 97: 501

    PubMed  CAS  Google Scholar 

  285. Kelly DA, Summerfield JA, Tuddenham EGD (1983) Localization of factor VIII: C antigen in guinea pig tissues. Thromb Haemost 50: 17 (Abstr)

    Google Scholar 

  286. Kelly DA, Summerfield JA, Tuddenham EGD (1984) Localization of factor VIIIC: antigen in guinea-pig tissues and isolated liver cell fractions. Br J Haematol 56: 535–543

    PubMed  CAS  Google Scholar 

  287. Kent TA, Pazdernik TL, Gunn WH, Penick EC, Marples BW, Jones MP, Goodwin DW (1983) Platelet uptake of serotonin in ethanol intoxication: a preliminary study. Biol Psychiatry 18: 929–933

    Google Scholar 

  288. Klein HJ, Falkensammer Ch, Gauss P, Fischer M (1975) Heparintherapie bei Leberzirrhose. Acta Med Austriaca 2: 99–103

    PubMed  CAS  Google Scholar 

  289. Kleinman Y, Friedman G (1982) Transient autoimmune thrombocytopenia associated with acute infectious hepatitis. Hepato-Gastroenterol 29: 144–145

    CAS  Google Scholar 

  290. Klingemann HG, Brunswig D, Liehr H (1976) Fibrinstruktur bei Hepatitis und Leberzirrhose. Verh Dtsch Ges Inn Med 82: 1649–1652

    PubMed  Google Scholar 

  291. Klingemann HG, Brunswig D, Liehr H (1978) Fibrinogen-und Fibrinstruktur bei Leberzirrhose. Z Gastroenterol 16: 564–573

    PubMed  CAS  Google Scholar 

  292. Klingemann HG, Egbring R, Havemann K (1980 a) Structure of fibrin and fibrinmonomer in renal and hepatic failure. Klin Wochenschr 58: 533–535

    Google Scholar 

  293. Klingemann HG, Schmidt U, Brunswig D, Egbring R, Kaffarnik H (1980b) Störungen der Blutgerinnung bei Leberzirrhose in Beziehung zum Ausmaß der portalen Hypertension. Fortschr Med 98: 1561–1566

    PubMed  CAS  Google Scholar 

  294. Knot EAR, Drijfhout H, Cate JW ten, Tijtgat GA (1983) Turnover studies of radiolabeled antithrom-bin III in liver disease. Thromb Haeamost 50: 121

    Google Scholar 

  295. Knot EAR, Drijfhout HR, Kahle LH, Ten Cate JW, Tijtgat GN (1984) Kinetic studies of radiolabel-led a2-antiplasmin and antithrombin III simultaneously in patients with liver disease. Haemostasis 14: 110 (Abstr)

    Google Scholar 

  296. Knot EAR, Ten Cate JW, Drijfhout HR, Kahle LH, Tytgat GN (1984) Antithrombin III metabolism in patients with liver disease. J Clin Pathol 37: 523–530

    PubMed  CAS  Google Scholar 

  297. Kobayashi N, Sudo J, Nagase K, Sakurada K, Yama H, Matsuzuka N, Chikama T, Shiraishi T, Sano M (1977) A study on hepaplastintest in liver diseases. Blood Vessel 8: 331–335

    Google Scholar 

  298. Koderisch H, Koderisch J, Bechtold H, Andrassy K, Ritz E (1984) Hämostasestörungen unter Zepha-losporinen der dritten Generation. 90. Tgg Dtsch Ges Inn Med, Wiesbaden 1984, S 439–440

    Google Scholar 

  299. Koj A, Regoeczi E, Toews CJ, Gauldie J (1978) Synthesis of antithrombin III and alpha!-antitrypsin by the perfused rat liver. Biochim Biophys Acta 539: 496–504

    PubMed  CAS  Google Scholar 

  300. Koller F ( 1983 a) Intoxikationen mit oralen Antikoagulantien (akzidentelle, iatogene, suizidale, hysterische und kriminelle). In: Koller F, Duckert F (Hrsg) Thrombose und Embolie. Schattauer, Stuttgart New York, S 330–334

    Google Scholar 

  301. Koller F (1983b) Venöse Thrombosen besonderer Lokalisation. In: Koller F, Duckert F (Hrsg) Thrombose und Embolie. Schattauer, Stuttgart New York, S 514–535

    Google Scholar 

  302. Koller F, Loeliger EA ( 1983 a) Interaktionen zwischen oralen Antikoagulantien und anderen Medikamenten. In: Koller F, Duckert F (Hrsg) Thrombose und Embolie. Schattauer, Stuttgart New York, S 318–322

    Google Scholar 

  303. Koller F, Loeliger EA (1983b) Nebenwirkungen der Antikoagulantien. In: Koller F, Duckert F (Hrsg) Thrombose und Embolie. Schattauer, Stuttgart New York, S 338–354

    Google Scholar 

  304. Kondo I, Kakiuchi S, Kato K, Takase K, Okuda Y, Tameda Y, Nakagiri S, Akeda S, Matsuda Y, Kato S, Kosaka Y, Takezawa H (1977) The significance of hepaplastintest in liver diseases. Blood Vessel 8: 336–340

    Google Scholar 

  305. Königshausen Th, Förster H, Trobisch H, Borchard F, Grabensee B, Hausamen TU (1976) Toxisches Leberzerfallskoma mit Verbrauchskoagulopathie nach Carbromal-Intoxikation. Med Welt 27: 330–332

    PubMed  Google Scholar 

  306. Kotitschke R, Scharrer J (1979) F VIIIR: Ag in Hepatitis. Thromb Haemost 42:126 Kotitschke R, Scharrer J (1980) F VIII R:Ag bei Hepatitis. Erfahrung mit einem Fertig-System. In: Schimpf Kl (Hrsg) Fibrinogen, Fibrin, Fibrinkleber. Schattauer, Stuttgart New York, S 441–447

    Google Scholar 

  307. Köttgen E, Schmölmerich J, Böttcher D, Diener W, Gerok W (1982) Untersuchungen zur Blutungs-neigung bei Aszitesreinfusion. Verh Dtsch Ges Inn Med 88: 1170–1173

    Google Scholar 

  308. Kroner Th (1973) ax-Antitrypsin-Mangel mit Hepatopathie und Eisenüberladung. Schweiz Med Wo-chenschr 103:1192–1195

    Google Scholar 

  309. Krummenerl T, Lohmann J, Kamanabroo D, Pott G, Wawerka J, Gerlach U (1983) Behandlung des akuten Leberversagens durch Plasmapherese. Dtsch Med Wochenschr 108: 261–266

    PubMed  CAS  Google Scholar 

  310. Kuntz HD (1982) Primär sklerosierende Cholangitis. Münch Med Wochenschr 124: 65–66

    Google Scholar 

  311. Kuntz HD, May B (1983) Veränderungen der Leberfunktion bei Schockleber und akuter Stauungsleber. Int Med 20: 17–20

    Google Scholar 

  312. Kuntz HD, Straub H (1982) Stauungsleber. Münch Med Wochenschr 124: 94–96

    CAS  Google Scholar 

  313. Kunz F, Amor H, Hörtnagl H, Weiser G, Holzknecht F, Braunsteiner H (1974) Disseminierte intravaskuläre Gerinnung und letale Makrothrombosierung bei einem Patienten mit Gallenwegs-karzinom. Dtsch Med Wochenschr 99: 2643–2647

    PubMed  CAS  Google Scholar 

  314. Kuto M, Konishi M, Tanaka T, Kanedo D, Yamaguchi T, Beppu H, Kusunose K, Deguchi K, Izuchi Y, Yamada S (1977) Studies on coagulation and fibrinolysis abnormalities in liver diseases. Blood Vessel 8: 99–104

    Google Scholar 

  315. Kuto M, Umemoto D, Kato M, Konishi M, Ito S, Morito T, Ree Sh, Deguchi K, Izuchi Y, Yamada S (1979) Studies on factor VIII complex in liver diseases. Blood Vessel 10: 350–356

    Google Scholar 

  316. Kwast Th van der, Stel HV, Veerman ECI, Bertina RM (1983) Localization of factor VIII C:Ag using different monoclonal antibodies against VIIIC. Thromb Haemost 50: 17 (Abstr)

    Google Scholar 

  317. Laggner A, Lenzhofer R (1981) Akzidentelle Vergiftung mit Tetrachlorkohlenstoff. Österr Ärzteztg 36: 937–939

    Google Scholar 

  318. Landolfi R, Leone G, Fedeli G, Storti S, Laghi F, Bizzi B (1980) Platelet-associated IgG in acute and chronic hepatic diseases. Scand J Haematol 25: 417–422

    PubMed  CAS  Google Scholar 

  319. Lane DA, Scully MF, Kakkar VV (1977 a) Prolonged thrombin clotting times in liver disease. Thromb Res 10: 773–774

    Google Scholar 

  320. Lane DA, Scully MF, Thomas DP, Kakkar VV, Woolf IL, Williams R (1977 b) Acquired dysfibrino-genaemia in acute and chronic liver disease. Br J Haematol 35: 301–308

    Google Scholar 

  321. Langley PG, Hughes RD, Williams R (1982) Platelet adhesiveness to glass beads in liver disease. Acta Haematol 67: 124–127

    PubMed  CAS  Google Scholar 

  322. Langley PG, Gove CD, Williams R (1984) Altered plasma and platelet lipids and their effect on platelet function in fulminant hepatic failure. 5. Intern Symp Ammonia, Semmering, 1984 (Abstr)

    Google Scholar 

  323. Larcan A (1978) Coagulopathies de consommation et intoxication aigues. Ann Med Nancy 17: 593–602

    Google Scholar 

  324. Latallo ZS (1981) Chromogenic substrates. In: Poller L (ed) Recent advances in blood coagulation 3. Livingstone, Edinburgh London Melbourne New York, pp 261–286

    Google Scholar 

  325. Laursen B, Mortensen JZ, Frost L, Hansen KB (1981) Disseminated intravascular coagulation in hepatic failure treated with antithrombin III. Thromb Res 22: 701–704

    PubMed  CAS  Google Scholar 

  326. Laursen B, Frost L, Mortensen JZ, Hanse KB, Paulsen SM (1983) Acute fatty liver of pregnancy with complicating disseminated intravascular coagulation. Acta Obstet Gynecol Scand 62: 403–408

    PubMed  CAS  Google Scholar 

  327. Lautz HU, Bartheis M, Schmidt E, Schmidt FW (1982) Präprothrombin bei akuter Virushepatitis B. Klin Wochenschr 60: 1423–1425

    PubMed  CAS  Google Scholar 

  328. Lechler E (1982) Prothrombinkomplexkonzentrate (Faktor II-VII-IX-X-Komplex). Eigenschaften und klinische Anwendung. Hämostaseologie 2: 116–127

    Google Scholar 

  329. Lechner K (1972) Immune reactive factor IX in acquired factor IX deficiency. Thromb Diath Hae-morrh 27: 19–24

    CAS  Google Scholar 

  330. Lechner K (1982) Laboratoriumsdiagnose hämatologischer Erkrankungen. 2. Blutgerinnungsstörungen. Springer, Berlin Heidelberg New York

    Google Scholar 

  331. Lechner K, Deutsch E (1967) Eine einfache Methode zur Herstellung von menschlichem Faktor VII-Mangelplasma. Thromb Diath Haemorrh 18: 252–258

    PubMed  CAS  Google Scholar 

  332. Lechner K, Thaler E (1976) Gerinnungsstörungen bei Lebererkrankungen. In: Harrer G, Zängl A (Hrsg) Kongreßband Van Swieten Tagung 1976. Verlag der Österreichischen Ärtzekammer, Wien, S 81–83

    Google Scholar 

  333. Lechner K, Fritsch A, Mach K, Benckdorff P, Reich N, Kux M, Boehmig HJ (1972) Intravascular coagulation in orthotopic transplantation of the canine liver. In: Kaulla KN von (ed) Coagulation problems in transplanted organs. Thomas, Springfield, pp 5–15

    Google Scholar 

  334. Lechner K, Bayer PH, Fill WD, Niessner H, Stych H, Thaler E, Thaler H, Weisskirchner R, Wewalka F (1975) Bestimmung von Gerinnungsfaktoren als Leberfunktionstest. In: Neumayr A (Hrsg) Aktuelle Probleme der klinischen Hepatologie. Witzstrock, Baden-Baden, S 41–51

    Google Scholar 

  335. Lechner K, Niessner H, Thaler E (1977) Coagulation abnormalities in liver disease. Semin Thromb Haemost 4: 40–56

    CAS  Google Scholar 

  336. Lechner K, Niessner H, Thaler E (1980) Angeborener und erworbener Antithrombin III-Mangel-ein prädisponierender Faktor zu lokalisierter und generalisierter intravaskulärer Gerinnung. In: Deutsch E, Lechner K (Hrsg) Fibrinolyse, Thrombose, Hämostase. Schattauer, Stuttgart New York, S 124–127

    Google Scholar 

  337. Lee SY, Chung SI (1976) Biosynthesis and degradation of plasma transglutaminase (factor XIII). FedProc 35: 1486

    Google Scholar 

  338. Lee WM (1979) Intravascular coagulation and ascites fluid infusion. Ann Intern Med 91: 319

    PubMed  CAS  Google Scholar 

  339. Lehmann H, Klein EE, Stutte HJ (1980) Die Lebervenen Verschlußkrankheiten. Klinik und Diagnostik des Budd-Chiari-Syndroms. Schweiz Med Wochenschr 110: 314–323

    Google Scholar 

  340. Lenz K, Kleinberger G, Druml W, Laggner A (1982) Die Schockleber. Leber Magen Darm 12: 198–202

    PubMed  CAS  Google Scholar 

  341. Leon M, Aiach M, Guennec JY, Jarnet J, Girot R, Fiessinger JN, Jaubert F (1982) Antithrombin III in rat hepatocytes. Thromb Res 28: 115–124

    PubMed  CAS  Google Scholar 

  342. Leone G, Agostini A, Mango G, Landolfi R, Valori VM, Bizzi B (1981) Megathrombocytes, platelet regeration time and platelet-associated IgG in idiopathic thrombocytopenic purpura and in thrombocytopenia associated with chronic liver disease. Acta Haematol 65: 40–47

    PubMed  CAS  Google Scholar 

  343. Lerner RG, Nelson JC, Corines P, Guercio LR del (1978) Disseminated intravascular coagulation: Complication of LeVeen peritoneovenous shunt. JAMA 240: 2064–2066

    Google Scholar 

  344. Levy RJ, Lian JB (1979) y-carboxyglutamic acid excretion and warfarin therapy. Clin Pharmacol Ther 25: 562–570

    Google Scholar 

  345. Lewis JH, Bontempo FA, Spero JA, Kang Y, Ragni MV, Starzl TE (1984) Liver transplantation: intraoperative coagulation findings. Haemostasis 14: 112 (Abstr)

    Google Scholar 

  346. Lieber ChS (1975) Liver disease and alcohol: Fatty liver, alcoholic hepatitis, cirrhosis, and their interrelationships. Ann NY Acad Sei 252: 63–84

    CAS  Google Scholar 

  347. Liebman H, Sandler R, Patch MJ, McGehee WG (1981) Disseminated intravascular coagulation in patients with fatty liver of pregnancy. Onset of DIC prior to labor. Thromb Haemost 46: 396

    Google Scholar 

  348. Liebman HA, Furie BC, Furie B (1982) Hepatic vitamin K-dependent carboxylation of blood-clotting proteins. Hepatology 2: 488–494

    PubMed  CAS  Google Scholar 

  349. Liehr H, Brunswig D, Grün M, Sautter Th (1978) Intestinale Endotoxine in der Pathogenese von Gerinnungsstörungen bei Lebererkrankungen. In: Heene DL (Hrsg) Immunolog Probleme der Blutgerinnung. Schattauer, Stuttgart New York, S 342–353

    Google Scholar 

  350. Liehr H, Doht F, Brugger G, Feldmann K, Brunswig D (1981) Zur Pathophysiologic von Antithrombin III und Alpha2-Makroglobulin bei Lebercirrhose. Verh Dtsch Ges Inn Med 87: 946–949

    Google Scholar 

  351. Lijnen HR, Jacobs G, Collen D (1981) Histidine-rich glycoprotein in a normal and clinical population. Thromb Res 22: 519–523

    PubMed  CAS  Google Scholar 

  352. Lipinski B, Lipinski I, Nowak A, Gurewich V (1977) Abnormal fibrinogen heterogeneity and fibrinolytic activity in advanced liver disease. J Lab Clin Med 90: 187–194

    PubMed  CAS  Google Scholar 

  353. Lipsky J J (1983a) N-Methyl-thio-tetrazole inhibiton of the gamma carboxylation of glutamic acid: possible mechanism for antibiotic-associated hypoprothrombinaemia. Lancet II: 192–193

    Google Scholar 

  354. Lipsky JJ (1983 b) Latamoxef-associated hypoprothrombinaemia. Lancet 11:624

    Google Scholar 

  355. Loeliger EA (1979) The optimal therapeutic range in oral anticoagulation. History and proposal. Thromb Haemost 42: 1141–1152

    PubMed  CAS  Google Scholar 

  356. Lombardi R, Mannucci PM, Seghatchian MJ, Garcia VV, Coppola R (1981) Alterations of factor VIII/von Willebrand factor in clinical conditions associated with an increase in its plasma concentration. Br J Haematol 49: 61–68

    PubMed  CAS  Google Scholar 

  357. Lösgen H, Brunner G, Schmidt FW (1982) Die Bedeutung des Plasmaaustausches für die Hämostase bei Patienten mit akutem und chronischen Leberversagen. Verh Dtsch Ges Inn Med 88: 1169–1170

    Google Scholar 

  358. Lyon J, Bookstein JJ, Cartwright CA, Romano A, Heeney DJ (1984) Peliosis hepatis: Diagnosis by magnification wedged hepatic venography. Radiology 150: 647–649

    Google Scholar 

  359. MacLennan FM, Ah-See AK, Wong AE, Andersen JA, Bennett B (1983) Severe depletion of vitamin K dependent clotting factors during postoperative latamoxef therapy. Lancet 1: 1215

    PubMed  CAS  Google Scholar 

  360. Mac Mahon AG (1973) Disseminated intravascular coagulation in acute alcoholic liver disease. S Afr Med J 47: 227–228

    Google Scholar 

  361. Maddrey WC (1984) Hepatic vein thrombosis (Budd-Chiari syndrome). Hepatology 4: 44S–46S

    PubMed  CAS  Google Scholar 

  362. Maeda Y, Soezima K, Takeda S, Takaki A, Ohsato K, Iwata Y (1977) Effect of heparin on coagulation and fibrinolysis in fulminant hepatic failure. Blood Vessel 8: 167–172

    Google Scholar 

  363. Maehara M, Kimura K, Sugaya H, Hisauchi T, Harada T, Kiyose H (1977) Blood coagulation activities in chronic liver diseases. Blood Vessel 8: 56–60

    Google Scholar 

  364. Mahdi S, Bopp E, Henke-Wolter J, Stockhausen HB v (1984) Zerebrale Blutung bei einem 4 Wochen alten Säugling mit homozygotem ax-Antitrypsinmangel. Klin Paediatr 196: 115–117

    CAS  Google Scholar 

  365. Malhotra OmP (1981) Dicumarol-induced prothrombins. Ann NY Acad Sei 370: 426–437

    CAS  Google Scholar 

  366. Malinverni R, Mombelli G (1983) Diffuse intravasale Gerinnung (DIC) bei Leberzirrhose? Eine Untersuchung mit Fibrinpeptid A (FPA). 51. Jahresversammlung Schweiz Ges Inn Med, Luzern, S 223

    Google Scholar 

  367. Mannucci PM, Mari D (1981) Hemostasis and liver disease. Haematologica 66: 233–248

    PubMed  CAS  Google Scholar 

  368. Mannucci PM, Vigano S (1982) Deficiencies of protein C an inhibitor of blood coagulation. Lancet 11: 463–466

    Google Scholar 

  369. Mannucci PM, Franchi F, Dioguardi N (1976) Correction of abnormal coagulation in chronic liver disease by combined use of fresh-frozen plasma and prothrombin complex concentrates. Lancet 11: 542–545

    Google Scholar 

  370. Mannucci PM, Boyer C, Wolf M, Tripodi A, Larrieu MJ (1982) Treatment of congenital antithrombin III deficiency with concentrates. Br J Haematol 50: 531–535

    PubMed  CAS  Google Scholar 

  371. Marassi A, Manzullo V, Carlo V di, Mannucci PM (1978) Thromboembolism following prothrombin complex concentrates and major surgery in severe liver disease. Thromb Haemost 39: 787–788

    PubMed  CAS  Google Scholar 

  372. Marchand C, Trzeciak MC, Follea G, Dechavanne M (1982) Sodium valproate and alterations in haemostasis. Nouv Press Med 11: 2718

    CAS  Google Scholar 

  373. Marongiu F, Mamusa AM, Solinas A, Demelia L, Mulas G, Perpignano G (1982) Plasmatic prekalli-krein ( Fletcher factor) in liver cirrhosis. Haematologica 67: 926–930

    Google Scholar 

  374. Marongiu F, Mamusa AM, Mameli G, Mulas D, Solinas A, Demelia L, Contu L (1984) a2-Antiplas-min and fibrinopeptide A in liver cirrhosis. Haemostasis 14:110 (Abstr)

    Google Scholar 

  375. Marosi L, Wittich G, Tscholakoff D, Pötzi R, Lochs H, Meryn S, Pollak Ch, Minar E (1982) Mirizzi-Snydrom. Dtsch Med Wochenschr 107: 1195–1197

    PubMed  CAS  Google Scholar 

  376. Martin JF, Bee D (1981) Acute liver failure and platelet aggregation. Thromb Res 22: 697–700

    PubMed  CAS  Google Scholar 

  377. Martinez J, Palascak JE (1979) Influence of the carbohydrate moiety in the dysfibrinogenemia of liver disease. Thromb Haemost 42: 189

    Google Scholar 

  378. Martinez J, Shapiro SS, Holburn RR, Ralph A, Carabasi RA (1973) Hypofibrinogenemia associated with hemangioma of the liver. Am J Clin Pathol 59: 192–197

    Google Scholar 

  379. Martinez J, Palascak JE, Kwasniak D (1978) Abnormal sialic acid content of the dysfibrinogenaemia associated with liver disease. J Clin Invest 61: 535–538

    PubMed  CAS  Google Scholar 

  380. Martinez J, Keane PM, Gilman PB (1983 a) Carbohydrate composition of normal fibrinogen compared to the abnormal fibrinogen in liver disease. Ann NY Acad Sei 408: 655–657

    Google Scholar 

  381. Martinez J, Keane PM, Gilman PB, Palascak JE (1983 b) The abnormal carbohydrate composition of the dysfibrinogenemia associated with liver disease. Ann NY Acad Sei 408: 388–396

    Google Scholar 

  382. Martinez J, MacDonald KA, Palascak JE (1983 c) The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains. Blood 61: 1196–1202

    Google Scholar 

  383. Martini GA (1982) Toxische arzneimittelbedingte Leberschäden. In: Gross R, Schölmerich P (Hrsg) Lehrbuch der Inneren Medizin, 6. Aufl. Schattauer, Stuttgart New York, S 720–722

    Google Scholar 

  384. Maruyama I, Kazama M, Yamanaka M, Mizuno Y, Tahara C, Hidano E, Abe T (1977) The relation between the activity and antigenicity of the factors of coagulation and fibrinolysis in liver diseases. Blood Vessel 8: 105–110

    Google Scholar 

  385. Matsuda M, Sakata Y, Yoshida N, Aoki N, Yamanaka T (1981) Plasma level of cold-insoluble globulin in liver diseases, especially in liver cirrhosis and its clinical implications. Blood Vessel 12: 65–68

    Google Scholar 

  386. Matsuda M, Yamaka T, Matsuda A (1982) Distribution of fibronectin in plasma and liver in liver diseases. Clin Chim Acta 118: 191–199

    PubMed  CAS  Google Scholar 

  387. Matsuno K, Terada H (1977) Investigations on the coagulation and platelet function in liver cirrhosis. Blood Vessel 8: 65–71

    Google Scholar 

  388. Matsuo T, Matsunaga K (1977) Fibrinolytic activity and serum lipids in patients with liver cirrhosis. Blood Vessel 8: 156–161

    Google Scholar 

  389. Matsushima A, Takahama Y, Inada Y (1982) Preparation of guinea pig antiserum to quantitate serum fragment D-dimer derived from cross-linked fibrin. Thromb Res 27: 111–115

    PubMed  CAS  Google Scholar 

  390. Matthias FR (1981) Interaktion von einigen Antithrombotika mit einigen anderen Pharmaka. In: Marx R, Thies HA (Hrsg) Kontrolle von Antithrombotika. Roche, Basel, S 261

    Google Scholar 

  391. Matthias FR (1982) Umsatzstörungen im Gerinnungs-und Fibrinolysesystem bei Erkrankungen der Leber. Verh Dtsch Ges Inn Med 88: 1347–1353

    Google Scholar 

  392. Mayer M, Herrmann I, Kempgens U, Queisser W (1977) In vivo labeling of platelets with 75Se-selenomethionine in patients with hepatic cirrhosis and thrombocytopenia. Thromb Haemost 37: 47–52

    PubMed  CAS  Google Scholar 

  393. McCarron MM, Gaddis GP (1981) Acute yellow phosphorus poisoning from pesticide pastes. Clin Toxicol 18: 693–711

    PubMed  CAS  Google Scholar 

  394. McClure St, Dincsoy HP1, Glueck H (1982) Budd-Chiari syndrome and antithrombin III deficiency. Am J Clin Pathol 78: 236–241

    PubMed  CAS  Google Scholar 

  395. Meguro T, Yamada K (1982) A simple and rapid test for PIVKA-II in plasma. Thromb Res 25: 109–114

    PubMed  CAS  Google Scholar 

  396. Meili EO, Feiten A von (1982) Anti-phospholipid-Antikörper können bei Haemophilen mit chro-nischer Hepatopathie Faktor (F.)VIII-Hemmkörper vortäuschen. 50. Jahresversammlung Schweiz Ges Inn Med, Lausanne 1982, S 92

    Google Scholar 

  397. Meili EO, Straub PW (1970) Elevation of factor VIII in acute fatal liver necrosis. Thromb Diath Haemorrh 24: 161–174

    PubMed  CAS  Google Scholar 

  398. Mizuguchi A, Kamogawa A, Iwabuchi S, Fujii M, Shizawa Y, Okabe K (1984) Studies on factor VIII complex in advanced liver diseases; large pore polacrylamide gel-crossed immunoelectro-phoretic patterns. Blood Vessel 15: 183–185

    Google Scholar 

  399. Morl M, Classen M, Demling L (1976) Nebenwirkungen von Laxantien auf die Leber. In: Wannagat L (Hrsg) Toxische Leberschäden. Thieme, Stuttgart, S 305–307

    Google Scholar 

  400. Mombelli G, Haeberle A, Rindiisbacher B, Straub PW (1983) Extra vaskulärer Katabolismus von Fibrin(ogen) und Spaltprodukten in Höhlenergüssen unterschiedlicher Genese. 51. Jahresversammlung Schweiz Ges Inn Med, Luzern 1983, S 26

    Google Scholar 

  401. Monreal M, Rodriguez R, Vanentin P, Monasterio J (1981) AT-III diagnostic and prognostic value in hepatic disease. Thromb Haemost 46: 372 (Abstr)

    Google Scholar 

  402. Morfini M, Biliotti G, Cinotti S, Turchi A, Marsiii M, Tonelli F, Grossi A, Cordopatri F, Lorenzi P, Rossi Ferrini P ( 1979 a) Liver devascularisation in pig. Alterations of coagulation and fibrinolysis. Thromb Haemost 42: 152

    Google Scholar 

  403. Morfini M, Martineiii F, Cinotti S, Boncinelli S, Mazzotta F, Paci P, Bandini S, Tonelli F, Cordopatri F, Morettini A, Pacini F, Rossi Ferrini P (1979 b) Coagulation disorders in fulminant hepatitis treated by dialysis. Thromb Haemost 42: 312

    Google Scholar 

  404. Morimoto S, Aosaki M, Ryono M, Hirosawa K, Hisamitsu T, Obata H (1978) Hepatic injury probably induced by warfarin. Report of a case. Blood Vessel 9: 286–290

    Google Scholar 

  405. Morse EE (1980) Fibrinogen and dysfibrinogenaemia. Ann Clin Lab Sei 10: 351–355

    CAS  Google Scholar 

  406. Mosvold J, Abildgaard U, Jenssen H, Andersen R (1982) Low antithrombin III in acute hepatic failure at term. Scand J Haematol 29: 48–50

    PubMed  CAS  Google Scholar 

  407. Movat AP (1982) Biliary disorders in childhood. Semin Liver Dis 2: 271–281

    Google Scholar 

  408. Mowat NAG, Brunt PW, Osgston D (1974) The fibrinolytic enzyme system in acute and chronic liver injury. Acta Haematol 52: 289–293

    PubMed  CAS  Google Scholar 

  409. Muller C, Fleischer J, Rennser F, Wolff H (1981) Das Gerinnungssystem bei Leberkrankheiten unter besonderer Berücksichtigung der Lebertransplantation. Z Ges Inn Med 36: 660–665

    PubMed  CAS  Google Scholar 

  410. Murakami A, Sato S, Kurosawa T, Kashiwabara T, Yoshida T, Suzuki K, Kaito L (1982) Early diagnosis of fulminant hepatitis: significance of blood coagulation and fibrinolytic activities. Blood Vessel 13: 556–560

    Google Scholar 

  411. Murphy KJ, Innis MD (1968) Hepatic disorder and severe bleeding diathesis following nitrofurantion ingestion. JAMA 204: 396–397

    PubMed  CAS  Google Scholar 

  412. Murr K, Grünst J, Eisenburg J, Hiller E, Zumtobel V (1980) Untersuchungen zur Frage der Genese der diffusen intravasalen Gerinnung nach Implantation der peritoneal-jugularen Shunts nach LeVeen. Klin Wochenschr 58: 85–90

    PubMed  CAS  Google Scholar 

  413. Murr K, Schüssler P, Rindfleisch GE, Eisenburg J, Hiller E (1981) Endotoxins and procoagulant activities of ascitic fluid. Thromb Haemost 46: 232 (Abstr)

    Google Scholar 

  414. Musumeci S, D’Agata A, Panebianco MG, Li Volti S (1975) Platelet and fibrinogen survival with 75Se-selenomethionine in acute infectious hepatitis. Thromb Diath Haemorrh 33: 493–500

    PubMed  CAS  Google Scholar 

  415. Nakamura K, Chisiro T, Suou T, Yoshioka T (1977) Studies on some clotting factors in liver diseases, particularly liver cirrhosis. Blood Vessel 8: 72–75

    Google Scholar 

  416. Nakao A (1984) The experimental study of blood coagulation and fibrinolysis in acute portal vein occlusion. Blood Vessel 15: 294–297

    Google Scholar 

  417. Nakaya H, Takada A, Kanayama R, Matsuda Y, Takase S, Nei J (1977) The indices determining the severity of the disease and evaluating the total functioning hepatic cell mass. Blood Vessel 8: 45–50

    Google Scholar 

  418. Namba T, Nolte CT, Jackrel J, Grob D (1971) Poisoning due to organophosphate insecticides. Am J Med 50: 475–492

    PubMed  CAS  Google Scholar 

  419. Nebbia G, Hadchouel M, Odievre M, Alagilley D (1983) Early assessment of evolution of liver disease associated with a!-antitrypsin deficiency in childhood. J Pediatr 102: 661–665

    PubMed  CAS  Google Scholar 

  420. Nemeth A, Strandvik B, Glaumann H (1983) a!-antitrypsin deficiency and juvenile liver disease. Ultrastructural observations compared with light microscopy and routine liver tests. Virchows Arch [Cell Pathol] 44: 15–34

    Google Scholar 

  421. Niiya K, Kitagawa T, Fujishita M, Yoshimoto S, Kobayashi M, Kubonishi I, Taguchi H, Miyoshi I (1983) Bulimia nervosa complicated by deficiency of vitamin K-dependent coagulation factors. JAMA 250: 792–793

    PubMed  CAS  Google Scholar 

  422. Nishibe H, Takahashi N, Tsukada K, Takeuchi T (1981) Quantitative analysis of oligosaccharides of fibrinogen and appearance of abnormal oligosaccharides in liver diseases. J Clin Chem Clin Biochem 19: 784

    Google Scholar 

  423. Odegard OR, Lie M, Abildgaard U (1975) Heparin cofactor activity measured with an amidolytic method. Thromb Res 6: 287–294

    PubMed  CAS  Google Scholar 

  424. Oehler G, Matthias FR (1980) Lösliches Fibrin im Plasma bei Patienten mit chronischen Erkrankungen der Leber. In: Schimpf Kl (Hrsg) Fibrinogen, Fibrin und Fibrinkleber. Schattauer, Stuttgart New York, S 135–139

    Google Scholar 

  425. Oehler G, Bleyl H, Roka L (1980) Immunologische Prothrombinbestimmung bei Patienten mit Leberkrankheiten. Blut 40: 52–53

    Google Scholar 

  426. Offenstadt G, Dessaint B, Conard J, Denis J, Pinta P, Herve JP, Robert A (1982) Syndrome de Budd-Chiari avec thrombose massive du système veineux sous-diaphragmatique et fibrinopenie majeure. Nouv Presse Méd 11: 2139–2141

    PubMed  CAS  Google Scholar 

  427. Ogura K, Yamauchi M, Kojima M, Kimura A, Inshikawa H, Kurihara N, Fujisawa K, Kameda H (1977) Significance of coagulation test in liver disease. Blood Vessel 8: 33–38

    Google Scholar 

  428. Oguri T, Sugawara Y, Sugie I, Yamamoto H (1977) Changes of antithrombin III, antiplasmins and antiactivator in liver diseases. Blood Vessel 8: 138–142

    Google Scholar 

  429. Oikawa I, Tamaki A, Saito I, Ikeda E, Kasai Y (1977) Studies on coagulation and fibrinolysis in patients with liver cirrhosis and primary liver carcinoma. Blood Vessel 8: 111–115

    Google Scholar 

  430. Ojiro M, Takenoshita M, Nishi M (1981) Coagulant and procoagulant factors in ascitic fluid.-About etiology of DIC induced by ascitic fluid infusion. Thromb Haemost 46: 396 (Abstr)

    Google Scholar 

  431. Oka K, Tanaka K (1977) Clinicopathological study on thrombus formation and disseminated intra-vascular coagulation in the liver diseases. Blood Vessel 8: 162–166

    Google Scholar 

  432. Oka K, Tanaka K (1979 a) Intravascular coagulation in autopsy cases with liver diseases. Thromb Haemost 42: 564–570

    Google Scholar 

  433. Oka K, Tanaka K (1979 b) Local fibrinolysis of esophagus and stomach as a cause of hemorrhage in liver cirrhosis. Thromb Res 14: 837–844

    Google Scholar 

  434. Okabe K, Watanabe Y (1978) Platelet ADP release reaction in cirrhosis of the liver. Blood Vessel 9: 436–439

    Google Scholar 

  435. Okabe K, Watanabe Y, Iwabuchi Sh, Otake K (1977) Coagulation and fibrinolysis in hepatic cirrhosis. Blood Vessel 8: 61–64

    Google Scholar 

  436. Okinaga Y, Kondo Sh, Ohki Y, Matsuo T (1980) Clinical significance of antithrombin III concentration with immunological and biological methods. Blood Vessel 11: 125–128

    CAS  Google Scholar 

  437. Olson JP, Miller LL, Troup StB (1963) Synthesis of coagulation factors by the in vitro perfused liver. Blood 22: 828

    Google Scholar 

  438. Ordinas A, Maragall S, Castillo R, Nurden AT (1978) A glycoprotein I defect in the platelets of three patients with severe cirrhosis of the liver. Thromb Res 13: 297–302

    PubMed  CAS  Google Scholar 

  439. O’Reilly RA, Aggeier PM (1976) Covert antocoagulant ingestion: Study of 25 patients and review of world literature. Medicine (Baltimore) 55: 389–399

    Google Scholar 

  440. Orlando M, Casalbore P, Camagna A, Lauro R, Tardeila L, Hassan HJ (1982) Factor VII in liver cirrhosis. Haemostasis 11: 73–78

    PubMed  CAS  Google Scholar 

  441. Ostermann H, Kirchhof B, Pott G (1982) Prothrombin determination in plasma and in liver biopsies in chronic liver diseases. Res Exp Med 180: 271–276

    CAS  Google Scholar 

  442. Osterud B, Lindahl U, Bogwald J, Seljelia R (1981) The extravascular coagulation system: the production of prothrombin, factor V, X, IX, VII and tissue factor in macrophages. Thromb Haemost 46: 14 (Abstr)

    Google Scholar 

  443. Owen CA Jr, Bowie EJW (1977) Generation of coagulation factors V, XI and XII by the isolated rat liver. Haemostasis 6: 205–212

    Google Scholar 

  444. Owen CA Jr, Bowie EJW (1978) Rat coagulation factors V, Vili, IX and XII: Vitamin K dependent. Haemostasis 7: 189–201

    Google Scholar 

  445. Owen CA Jr, Bowie EJW (1981) Generation of plasmatic coagulation factors by the isolated rat liver perfused with completely synthetic blood substitute. Thromb Res 22: 259–266

    PubMed  CAS  Google Scholar 

  446. Owen CA Jr, Goldstein NP, Bowie EJW (1976) Platelet function and coagulation in patients with Wilson disease. Arch Intern Med 136: 148–152

    PubMed  Google Scholar 

  447. Owen CA Jr, Bowie EJW, Fass DN (1979) Generation of factor VIII:C by isolated pig and rat livers. Thromb Haemost 42: 112

    Google Scholar 

  448. Owens MR, Cimino CD (1982) Synthesis of fibronectin by the isolated perfused rat liver. Blood 59: 1305–1309

    PubMed  CAS  Google Scholar 

  449. Owren PA (1977) Blood coagulation in liver diseases. Blood Vessel 8: 1–22

    Google Scholar 

  450. Oyabu H, Tsumoto S, Toda H, Sugiyama S, Kageyama T (1980) Studies on coagulation and fibrinolysis in hepatic diseases. Blood Vessel 11: 291 — 295

    Google Scholar 

  451. Pabinger I, Deutsch E (1984) Diskussionsbeitrag zu Heene DL. Bildungs-und Umsatzstörungen im Gerinnungssystem. In: Tilsner V, Matthias FR (Hrsg) Leber, Blutgerinnung und Hämostase. XXVII. Hamburger Symposion über Blutgerinnung 1984 (im Druck)

    Google Scholar 

  452. Palareti G, Poggi M, Coccheri S (1981) Fibrinogen in liver cirrhosis. Sialic acid content of fibrinogen in moderate and severe cirrhosis and relation to thrombin time. Thromb Haemost 46: 358 (Abstr)

    Google Scholar 

  453. Palareti G, Bernardi M, Poggi M, Caletti GC, Tricarico MG, Coccheri S (1982) Consumption of platelets and clotting factors after injection sclerotherapy of oesophageal varices in liver cirrhosis. Haemostasis 12: 38

    Google Scholar 

  454. Palascak JE, Martinez J (1977) Dysfibrinogenemia associated with liver disease. J Clin Invest 60: 89–95

    PubMed  CAS  Google Scholar 

  455. Palmer PE, Gherardi GJ, Baldwin JM, Wolfe HJ (1978) Adult liver disease in SZ phenotype alpha–1-antitrypsin deficiency. Ann Intern Med 88: 59–60

    PubMed  CAS  Google Scholar 

  456. Patrassi GM, Martinelli S, Sgarabotto D, Sturmiolo GC, Girolami A (1984) Fibrinolytic study in plasma and ascites fluid of cirrhotic patients before and after peritoneovenous shunt. Haemostasis 14: 109

    Google Scholar 

  457. Pengo V, Bertaglia E, Carmignoto F, Schivo P, Guerra C (1981) Polimerizzazione anomala della fibrina e sua rilevanza clinica in gruppi di pazienti con epatopatia cronica. Haematologica 66: 171–180

    PubMed  CAS  Google Scholar 

  458. Philipp H, Böhm N, Lesch R, Zimmermann WE, Heimbach W (1977) Akute Lebervenenverschluß-krankheit mit Pfortaderthrombose, Milzruptur und Leberversagen. Med Welt 28: 587–590

    Google Scholar 

  459. Phillips LL, Rodgers JB (1979) Procoagulant properties of ascitic fluid in hepatic cirrhosis. Thromb Haemost 42: 152

    Google Scholar 

  460. Philo RD, Gaffney PJ (1982) Comparison of antithrombin III assays using biological and chromo-genic substrates. Br J Haematol 50: 147–156

    PubMed  CAS  Google Scholar 

  461. Pitney WR (1981) Anticoagulant drugs. In: Pitney WR (ed) Venous and arterial thrombosis. Livingstone, Edinburgh London Melbourne New York, pp 169–187

    Google Scholar 

  462. Podolsak B, Ströder J (1974) Störungen von Thrombozytenfunktionen während der ikterischen Phase der akuten Virushepatitis. Z Kinderheilk 116: 153–176

    PubMed  CAS  Google Scholar 

  463. Poller L (1977) Coagulation abnormalities in liver disease. In: Poller L (ed) Recent advances in blood coagulation. Livingstone, Edinburgh London New York, pp 267–292

    Google Scholar 

  464. Pomeroy C, Knodell RG, Swaim WR, Arneson P, Mahowald ML (1983) Budd-Chiari syndrome in a patient with the lupus anticoagulant. Gastroenterology 86: 158–161

    Google Scholar 

  465. Pool JP, Robinson J (1959) In vitro synthesis of coagulation factors by rat liver slices. Am J Physiol 196: 423–428

    PubMed  CAS  Google Scholar 

  466. Popper H, Gerber MA (1976) Klassifizierung von Leberschäden, die auf Arzneimittel und Chemikalien zurückzuführen sind. In: Wannagat L (Hrsg) Toxische Leberschäden. Thieme, Stuttgart, S 87–99

    Google Scholar 

  467. Poser JW, Esch FS, Ling NC, Price PA (1980) Isolation and sequence of the vitamin K-dependent protein from human bone. J Biol Chem 255: 8685–8691

    PubMed  CAS  Google Scholar 

  468. Pott G, Kamanabroo D, Krummenerl Th, Lohmann J, Gerlach U (1983) Therapie des akuten Leberversagens. Dtsch Med Wochenschr 108: 1327–1329

    PubMed  CAS  Google Scholar 

  469. Prescott LF, Cregeen RJ (1982) The hepatotoxicity of praracetamol. Clinical aspects. Agressologie 23 A: 17–20

    Google Scholar 

  470. Preston FE, Malia RG, Lilleyman JS, Blackburn EK (1977) Heparinised clotting factor concentrates in patients with Christmas disease and liver disease. Thromb Haemost 38: 504–509

    PubMed  CAS  Google Scholar 

  471. Princen HMG, Selten GCM, Nieuwenhuizen W, Yap SH (1983) Changes of synthesis of fibrinogen polypeptide and albumin messenger RNAs in rat liver after turpentine injection and after partial hepatectomy or laparotomy. In: Haverkate F, Henschen A, Nieuwenhuizen W, Straub PW (eds) Fibrinogen structure, functional aspects, metabolism, de Gruyter, Hawthorne, pp 263–278

    Google Scholar 

  472. Prochazka J, Hauftova D (1965) Changes of some clotting factors in hepatolenticular degeneration ( Wilson’s disease ). Gastroenterologia 104: 325–334

    Google Scholar 

  473. Prowse CV, Cash JD (1981) The use of factor IX concentrates in man: a 9-year experience of Scottish concentrates in the south-east of Scotland. Br J Haematol 47: 91–104

    PubMed  CAS  Google Scholar 

  474. Prydz H (1964) Studies on proconvertin (factor VII) V. Biosynthesis in suspension cultures of rat liver cells. Scand J Clin Lab Invest 16: 540–548

    PubMed  CAS  Google Scholar 

  475. Prydz H (1977) Vitamin K-dependent clotting factors. Semin Thromb Haemost 4: 1–14

    CAS  Google Scholar 

  476. Ragni MV, Lewis JH, Hasiba U, Spero JA (1980) Prekallikrein ( Fletcher factor) deficiency in clinical disease states. Thromb Res 18: 45–54

    Google Scholar 

  477. Ragni MV, Lewis JH, Spero JA (1983) Ascites-induced LeVeen shunt coagulopathy. Ann Surg 198: 91–95

    PubMed  CAS  Google Scholar 

  478. Rak K (1983) Attempt to better assess the haemostatic functions in patients with chronic liver diseases (CLD). Thromb Haemost 50: 273 (Abstr)

    Google Scholar 

  479. Rak K, Boda Z, Misz M, Beck P (1981) Antithrombin III in chronic liver diseases. Thromb Haemost 46: 370 (Abstr)

    Google Scholar 

  480. Ratnoff OD (1977) The hemostatic defects of liver diseases. In: Ogston D, Bennett B (eds) Haemosta-sis: Biochemistry, physiology and pathology. Willey, London New York Sydney Toronto, pp 446–466

    Google Scholar 

  481. Raum D, Levy R, Taylor PD, Starzl ThE (1980) Synthesis of human plasminogen by the liver. Science 208: 1036–1037

    PubMed  CAS  Google Scholar 

  482. Rehnqvist N (1978) Intrahepatic jaundice due to warfarin therapy. Acta Med Scand 204: 335–336

    PubMed  CAS  Google Scholar 

  483. Reiffers J, Couzigou P, Vuillemin L, Amouretti M, Beraud C, Ducassou D (1981) Indium labeled platelet kinetics in ascitic cirrhosis. Thromb Haemost 46: 418 (Abstr)

    Google Scholar 

  484. Reinhardt D, Goebel U, Puetter J (1981) Isoniacid Intoxikation: Beziehung zwischen Blutspiegel und Gerinnungsstörungen? Klin Pädiatr 193: 122–124

    PubMed  CAS  Google Scholar 

  485. Ren P, Stark PY, Johnson RL, Bell RG (1977) Mechanism of action of anticoagulants: correlation between the inhibition of prothrombin synthesis and the regeneration of vitamin Kx from vitamin Kx epoxide. J Pharmacol Exp Ther 201: 541–546

    PubMed  CAS  Google Scholar 

  486. Rentsch J, Sickor HJ, Zenker K, Ebermann W, Stosiek P (1983) Akute Schwangerschafsleber-eine Kasuistik. Dtsch Gesundh-Wesen 38: 717–719

    Google Scholar 

  487. Ritchie DG, Fuller GM (1983) Hepatocyte-stimulating factor. A monocyte-derived acute-phase regulatory protein. Ann NY Acad Sei 408: 490–500

    Google Scholar 

  488. Ritland S, Skrede S, Blomhoff JP, Gjone E (1973) Coagulation factors as indicators of protein synthesis in chronic liver disease. Scand J Gastroenterol [Suppl 19] 8: 113–117

    Google Scholar 

  489. Roberts HR, Cederbaum AI (1972) The liver and blood coagulation: Physiology and pathology. Gastroenterology 63: 297–320

    Google Scholar 

  490. Roberts HR, Griffith MJ, Braunstein KM, Lundblad RL (1981) Structural abnormalities of the vitamin K-dependent clotting factors. In: Menache D, MacN Surgenor D, Anderson H (eds) Hemophilia and hemostasis. Liss, New York, pp 85–102

    Google Scholar 

  491. Rodeghiero F, Mannucci PM, Vigano S, Barbui T, Gugliotta M, Cortellaro M, Dini E (1984) Liver dysfunction rather than intravascular coagulation as the main cause of low protein C and antithrombin III in acute leukemia. Blood 63: 965–969

    PubMed  CAS  Google Scholar 

  492. Rodzynek J J, Urbain D, Leautuad P, Wettendorf P, Delcourt A (1983) Antithrombin III, plasminogen and a2-antiplasmin in jaundice. Thromb Haemost 50: 49 (Abstr)

    Google Scholar 

  493. Rodriguez-Erdman F (1978) Acquired hypofibrinogenemias: differential diagnosis between liver disease and intravascular coagulation. XVII. Congr Int Soc Hematol Paris 1978, p 939

    Google Scholar 

  494. Roody H, Putnam ChW, Fennell RH (1976) Pathology of liver transplantation. Transplantation 22: 625–630

    Google Scholar 

  495. Rubin MH, Weston MJ, Langley PG, White Y Williams R (1979) Platelet function in chronic liver disease. Relationship to disease severity. Dig Dis Sei 24: 197–202

    Google Scholar 

  496. Rubin RN, Kies MS, Posch JJ (1980) Measurements of antithrombin III in solid tumor patients with and without hepatic metastases. Thromb Res 18: 353–360

    PubMed  CAS  Google Scholar 

  497. Ruegg R, Straub PW (1980) Exchange between intravascularly and extravascularly injected radioiodi-nated fibrinogen and its in vivo derivatives. J Lab Clin Med 95: 842–856

    PubMed  CAS  Google Scholar 

  498. Saba TM, Jaffe E (1980) Plasma fibronectin (opsonic glycoprotein): its synthesis by vascular endothelial cells and role in cardiopulmonary integrity after trauma related to reticuloendothelial function. Am J Med 68: 577–594

    PubMed  CAS  Google Scholar 

  499. Saito H, Goldsmith GH Jr (1977) Plasma thromboplastin antecedent (PTA, Factor XI ): A specific and sensitive radioimmunoassay. Blood 50: 377–385

    Google Scholar 

  500. Saito H, Poon MC, Vicic W, Goldsmith GH Jr, Menitove JE (1978) Human plasma prekallikrein ( Fletcher factor) clotting activity and antigen in health and disease. J Lab Clin Med 92: 84–95

    Google Scholar 

  501. Saito H, Hamilton SM, Tavill AS, Louis L, Ratnoff OD (1980) Production and release of plasminogen by isolated perfused rat liver. Proc Natl Acad Sei 77: 6837–6840

    CAS  Google Scholar 

  502. Salem HH, Koutts J, Handley Ch, Weyden MB van der, Dudley FJ, Firkin BG (1981) The aggregation of human platelets by ascitic fluid: a possible mechanism for disseminated intravascular coagulation complicating LeVeen shunts. Am J Hematol 11: 153–157

    PubMed  CAS  Google Scholar 

  503. Salem HH, Dudley FJ, Merrett A, Perkin J, Firkin BG (1983) Coagulopathy of peritoneovenous shunts: studies on the pathogenetic role of ascitic fluid collagen and value of antiplatelet therapy. Gut 24: 412–417

    PubMed  CAS  Google Scholar 

  504. Sbarbaro JA, Bennett RM (1977) Aspirin hepatotoxicity and disseminated intravascular coagulation. Ann Intern Med 86: 183–185

    PubMed  CAS  Google Scholar 

  505. Schäfer K, Ukida M, Bode JCh (1982) Aminosäurekonzentration im Plasma bei Lebernekrose nach Tetrachlorkohlenstoffvergiftung. Dtsch Med Wochenschr 107: 860

    PubMed  Google Scholar 

  506. Schaps D, Hempelmann G, Pichlmayr R (1978) Zur orthotopen Lebertransplantation aus anaesthe-siologischer Sicht. Anaesthesist 27: 405–415

    PubMed  CAS  Google Scholar 

  507. Scharf RE, Heisig S, Schramm W, Berges W, Schneider W (1982 a) Radioimmunologische Untersuchungen zur Thrombozytopenie bei kompensierter Leberzirrhose. Acta Med Austriaca 9: 129

    Google Scholar 

  508. Scharf RE, Schramm W, Heisig S, Schneider W (1982 b) Does chronic disseminated intravascular coagulation (DIC) cause thrombocytopenia in patients with stable liver cirrhosis? Haemostasis 12 [Suppl 1]: 39

    Google Scholar 

  509. Scharf RE, Schneider W, Heisig S, Schramm W (1983) Thrombozytopenie bei Leberzirrhose. Klin Wochenschr 61: 703–708

    PubMed  CAS  Google Scholar 

  510. Scharf RE, Schneider W (1984) Klinische, biochemische und zytomorphometrische Aspekte zur Thrombozytopenie und Thrombozytopathie bei Leberzirrhose. Haemostasis 4: 43–49

    Google Scholar 

  511. Schimpf K (1982) Lebererkrankungen durch Therapie von Hämostasestörungen. Verh Dtsch Ges Inn Med 88: 1354–1361

    Google Scholar 

  512. Schimpf Kl, Zimmermann K (1980) Hepatitishäufigkeit, serologische Befunde und Leberhistologie nach Therapie schwerer hämorrhagischer Diathesen mit Gerinnungsfaktorenkonzentraten. In: Schimpf Kl (Hrsg) Fibrinogen, Fibrin, Fibrinkleber. Schattauer, Stuttgart, S 299–308

    Google Scholar 

  513. Schipper HG, Lamping R, Kahle L, Ten Cate JW (1979) Antithrombin III transfusion in patients with liver cirrhosis. Thromb Haemost 42: 327

    Google Scholar 

  514. Schipper HG, ten Cate JW (1982) Antithrombin III transfusion in patients with hepatic cirrhosis. Br J Haemat 52: 25–34

    CAS  Google Scholar 

  515. Schmid M (1975) Umweltbedingte Leberschäden. In: Neumayr A (Hrsg) Aktuelle Probleme der klinischen Hepatologie. Witzstrock, Baden-Baden Brüssel, S 1–11

    Google Scholar 

  516. Schmidt H, Bartels O, Strömmer P, Wagner-Thiessen E (1983) Akutes Leberversagen bei abdominellem Morbus Wilson im frühen Erwachsenenalter. Dtsch Med Wochenschr 108: 614–618

    PubMed  CAS  Google Scholar 

  517. Schmidt PM (1983) Anomalies hematologiques dans la cirrhose ethylique. Schweiz Med Wochenschr 113: 1030–1034

    Google Scholar 

  518. Schmidt-Wilcke HA, Wolfert W, Grundmann E (1977) Halothan und Tuberkulostatika als hepatoto-xische Arzneimittelkombination. Z Gastroenterol 15: 504–511

    PubMed  CAS  Google Scholar 

  519. Schmitz-Huebner U, Kamanabroo D, Asbeck F (1978) Spontane F VIII-Hemmkörper-Bildung als Komplikation der akuten Hepatitis? Verh Dtsch Ges Inn Med 84: 1363–1364

    Google Scholar 

  520. Schneider W, Girmann G, Wagner HJ (1975) Mordversuch mit Phenprocuman ( Marcoumar ). Dtsch Med Wochenschr 100: 1838–1841

    Google Scholar 

  521. Schneider W, Scharf RE, Schramm W (1982) Thrombozyten und Lebererkrankungen. Verh Dtsch Ges Inn Med 88: 1336–1339

    Google Scholar 

  522. Schneider W, Winkelmann M, Schmitz G, Aul C, Scharf R, Pfitzer P (1983) Stages of maturity and ploidy pattern of megakaryocytes in patients with hepatic cirrhosis. Thromb Haemost 50: 166 (Abstr)

    Google Scholar 

  523. Schöndorf TH, Pralle H, Graubner M (1982) Hypercoagulability due to antithrombin Ill-decrease under long-term asparaginase administration Blut 45: 199

    Google Scholar 

  524. Schramm W (1982) Hämostasestörungen bei Lebererkrankungen. Die Rolle des Inhibitorpotentials (AT-III). Verh Dtsch Ges Inn Med 88: 1340–1346

    CAS  Google Scholar 

  525. Schramm W (1983) Erfahrungen mit der Substitution von Antithrombin III-Konzentraten bei angeborenen und erworbenen Mangelzuständen. Behring Werke Mitt 73: 66–78

    Google Scholar 

  526. Schramm W, Marx R (1980) Zur Behandlung thrombophiler Diathesen-Substitution mit Antithrom-bin-III-Konzentrat. In: Deutsch E, Lechner K (Hrsg) Fibrinolyse, Thrombose, Hämostase. Schattauer, Stuttgart, S 491–494

    Google Scholar 

  527. Schuster HP, Prellwitz W, Schönborn H, Olbermann M (1976) Blutgerinnungsstörungen als Mitursache massiver gastrointestinaler Blutungen bei Patienten mit Leberzirrhose. Med Welt 27: 1392–1394

    PubMed  CAS  Google Scholar 

  528. Schwartz ML, Swaim WR, Vogel SB (1979) Coagulopathy following peritoneovenous shunting. Surgery 85: 671–676

    PubMed  CAS  Google Scholar 

  529. Schwarz HP, Aiginger P, Kuzmits R (1982) Influence of Mithramycin on fibrinolytic inhibitors. Blut 45: 212

    Google Scholar 

  530. Scott J, Gollan JL, Samourian S, Sherlock Sh (1978) Wilson’s disease, presenting as chronic active hepatitis. Gastroenterology 74: 645–651

    PubMed  CAS  Google Scholar 

  531. Seligsohn U, Shani M, Ramot B (1970a) Gilbert Syndrom and factor VII deficiency. Lancet 1: 1398

    Google Scholar 

  532. Seligsohn U, Shani M, Ramot B, Adam A, Sheba Ch (1970b) Dubin Johnson Syndrome in Israel. II. Association with factor VII-deficiency. Q J Med XXXIX: 569–584

    Google Scholar 

  533. Shani M, Seligsohn U, Gilon E, Sheba Ch, Adam A (1970) Dubin Johnson Syndrome in Israel. I. Clinical, laboratory and genetic aspects of 101 cases. Q J Med XXXIX: 549–567

    Google Scholar 

  534. Sharoni Y, Berger H Jr (1984) Human hepatocytes secrete mainly a latent form of tissue plasminogen activator. Haemostasis 14: 108

    Google Scholar 

  535. Sharoni Y, Topal MC, Tuttle PR, Berger H (1982) A comparison of plasminogen activators derived from rat plasma, primary rat hepatocytes and isolated perfused rat liver. Thromb Haemost 47: 166–172

    PubMed  CAS  Google Scholar 

  536. Sharp HL (1982) Alpha–1-antitrypsin: An ignored protein in understanding liver diseases. Semin Liver Dis 2: 314–328

    PubMed  CAS  Google Scholar 

  537. Shaw E, Giddings JC, Peake IR, Bloom AL (1979) Synthesis of procoagulant factor VIII, factor VIII related antigen and other coagulation factors by the isolated perfused rat liver. Br J Haematol 41: 585–596

    PubMed  CAS  Google Scholar 

  538. Sherlock DS (1981) Diseases of the liver and biliary system, 6th edn. Blackwell, Oxford

    Google Scholar 

  539. Sherlock Sh (1982) Non cirrhotic extrahepatic and intrahepatic portal hypertension. Semin Liver Dis 21: 202–210

    Google Scholar 

  540. Sherman LA, Lee J (1982) Fibronectin: Blood turnover in normal animals and during intravascular coagulation Blood 60: 558–563

    CAS  Google Scholar 

  541. Shifman MA, Pizzo SV (1982) The in vivo metabolism of antithrombin III and antithrombin Ill-complexes. J Biol Chem 257: 3243–3248

    PubMed  CAS  Google Scholar 

  542. Siegert W, Lohrs U, Eisenburg J (1981) Hepatosplenomegalie und hämorrhagische Diathese. Internist 22: 49–51

    PubMed  CAS  Google Scholar 

  543. Siemensma NP, Bathal PS, Pennington DG (1975) The effect of massive liver resection on platelet kinetics in the rat. J Lab Clin Med 86: 817–833

    PubMed  CAS  Google Scholar 

  544. Smokovitis A (1979) Normal liver actually possesses a high vascular plasminogen activator activity. Experientia 35: 776–777

    PubMed  CAS  Google Scholar 

  545. Soff GA, Levin J (1981) Familial Multiple coagulation factor deficiencies I. Review of the literature: Differentiation of single hereditary disorders associated with multiple factor deficiencies from coincidental concurrence of single factor deficiency states. Semin Thromb Haemost 7: 112–148

    Google Scholar 

  546. Solomon GE, Hilgartner MW, Kutt H (1972) Coagulation defects caused by diphenylhydantoin. Neurology 22: 1165–1171

    PubMed  CAS  Google Scholar 

  547. Soria J, Soria C, Ryckewaert J J, Samama M ( 1979 a) Abnormalities in fibrin formation in hepatic disease. Consequences of acquired dysfibrinogenemia on fibrin formation and on platelet aggregation cofactor activity. Thromb Haemost 42: 188

    Google Scholar 

  548. Soria J, Soria C, Ryckewaert J J, Thomson J, Poller L, Samana M (1979 b) Diagnosis of an acquired dysfibrinogenemia in severe hepatitis. Int Soc Haematol Europ Afric Div 5. Meeting Hamburg III, p 104

    Google Scholar 

  549. Soria J, Soria C, Ryckewaert JJ, Samama M, Thomson JM, Poller L (1980) Study of acquired dysfibrinogenemia in liver disease. Thromb Res 19: 29–41

    PubMed  CAS  Google Scholar 

  550. Soulier JP (1982) Syndrome de Budd-Chiari avec thrombose massive du système veineux sous-dia-phragmatique et fibrinopénie majeure. Nouv Press Méd 11: 2718

    Google Scholar 

  551. Stakeberg H (1974) Substrate incorporation into lipids and proteins in human liver slices. Acta Med Scand [Suppl] 561: 7–30

    Google Scholar 

  552. Starzl TE (1980) Orthotopic liver transplantation. Biol Bone Marrow Transplant 17: 545

    Google Scholar 

  553. Starzl TE, Porter KA, Putnam CW, Schroter GPJ, Halgrimson CG, Weil R, Hoelscher M, Reid HAS (1976) Orthotopic liver transplantation in 93 patients. Surg Gynecol Obstet 142: 487–505

    PubMed  CAS  Google Scholar 

  554. Stein F, Harker LA (1979) The evaluation of hemostasis in patients with hepatic cirrhosis. Thromb Haemost 42: 151

    Google Scholar 

  555. Stein SF, Harker LA (1982) Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis. J Lab Clin Med 99: 217–230

    PubMed  CAS  Google Scholar 

  556. Stel HV, Kwast ThH van der, Veerman ECI (1983) Detection of factor VHI/coagulant antigen in human liver tissue. Nature 303: 530–532

    PubMed  CAS  Google Scholar 

  557. Stemberger A, Vogel G, Fritsche HM, Fischer M, Bottermann P, Bliimel G (1979) Management of hemostasis in acute liver failure. Thromb Haemost 42: 152

    Google Scholar 

  558. Stenberg B, Alpsten M, Kjellström T, Risberg B (1981 a) The effect of tranexamic acid on experimental gastric haemorrhage. Thromb Haemost 46:387 (Abstr)

    Google Scholar 

  559. Stenberg B, Peterson HI, Risberg B (1981b) Gastric tissue fibrinolytic activity in experimental ulcer disease. In: Davidson JF, Nilsson IM, Astedt B (eds) Progress in fibrinolysis. Livingstone, London Melbourne New York, pp 295–297

    Google Scholar 

  560. Stenberg B, Karlsson L, Alpsten M, Risberg B (1982) Reduction of gastric haemorrhage-Effect of antifibrinolytic agents versus H2-blocking agents. Haemostasis 11 [Suppl 1]: 24

    Google Scholar 

  561. Stratta P, Canavese C, Peiretti F, Vallauri P, Vercellone A (1983) Warning: Platelet factor 4, ß-thromboglobulin and thromboxane in Donor’s plasma units. Thromb Haemost 49: 61

    PubMed  CAS  Google Scholar 

  562. Straub PW (1977) Diffuse intravascular coagulation in liver disease? Semin Thromb Haemost 4: 29–39

    CAS  Google Scholar 

  563. Suchy FJ, Balistreri WF, Buchino JJ, Sondheimer JM, Bates SR, Kearns GL, Stull JD, Bove KE (1979) Acute hepatic failure associated with the use of sodium valproate. N Engl J Med 300: 962–966

    PubMed  CAS  Google Scholar 

  564. Sultan Y, Maisonneuve P, Simeon J, Intrator L (1977) Modifications of factor VIII related antigen in haemophiliacs with acute hepatitis and subclinical liver disease. Scand J Haemat [Suppl 1] 30: 16–26

    CAS  Google Scholar 

  565. Sussman NM, McLain LW (1979) A direct hepatotoxic effect of valproic acid. JAMA 242: 1173–1174

    PubMed  CAS  Google Scholar 

  566. Suttie JW (1980) The metabolic role of vitamin K. Fed Proc 39: 2730–2735

    PubMed  CAS  Google Scholar 

  567. Svoboda JA, Peter ET, Dang CV, Parks SN, Ellyson JH (1982) Severe liver trauma in the face of coagulopathy. A case for temporary packing and early reexploration. Am J Surg 144: 717–721

    Google Scholar 

  568. Swanson JC, Suttie JW (1982) Vitamin K dependent in vitro production of prothrombin. Biochemistry 21: 6011–6018

    PubMed  CAS  Google Scholar 

  569. Takamiya O, Yoshioka K, Sakata M, Yoshikawa I (1980) Immunologic assay of Factor XII by Laurell’s method. Blood Vessel 11: 26–30

    CAS  Google Scholar 

  570. Takeda Sh, Ishibushi T, Takaki A, Ohsato K (1977) Hemostatic studies in obstructive jaundices. Blood Vessel 8: 121–126

    Google Scholar 

  571. Tamaki A, Kawanishi N, Saitoh I, Ikeda E, Oikawa I, Kasai Y, Inoue K (1977) Changes in some blood coagulation factors and in fibrinolysis on hepatic operation. Blood Vessel 8: 179–182

    Google Scholar 

  572. Tanaka M, Kato K (1981) Determination of antithrombin III by sandwich enzyme immunoassay technique. Thromb Res 22: 67–74

    PubMed  CAS  Google Scholar 

  573. Tanikawa K, Abe H, Maeyama T (1977) Heparin treatment for acute hepatic failure. Blood Vessel 8: 173–178

    Google Scholar 

  574. Tein AN (1977) Heparin elimination in patients with liver cirrhosis. Thromb Haemost 38: 701–706

    Google Scholar 

  575. Thaler E (1981) Pathogenese und klinische Bedeutung des erworbenen Antithrombin III-Mangels in der inneren Medizin. Wien Klin Wochenschr 93: 563–572

    PubMed  CAS  Google Scholar 

  576. Thaler E (1982) Antithrombin III-Konzentrate: Klinische Anwendung. Hämostaseologie 2: 128–136

    Google Scholar 

  577. Thaler H (1982) Leberkrankheiten. Springer, Berlin Heidelberg New York, S 177

    Google Scholar 

  578. Thaler H (1983) Der medikamentös induzierte Ikterus. Acta Med Austriaca 10: 113–116

    PubMed  CAS  Google Scholar 

  579. Thaler E, Kleinberger G (1982) Die hepatische Koagulopathie-Grundlagen und therapeutische Ansätze. Leber Magen Darm 12: 193–197

    PubMed  CAS  Google Scholar 

  580. Thaler E, Lechner K (1981) Antithrombin III deficiency and thromboembolism. Clin Haematol 10: 369–390

    PubMed  CAS  Google Scholar 

  581. Thoghill PJ, Green S (1983) Platelet dynamics in chronic liver disease using the 11 indium oxine label. Gut 24: 49–52

    Google Scholar 

  582. Thorn GW, Adams RD, Braunwald E, Isselbacher KJ, Petersdorf RG (1977) Harrison’s principles of internal medicine, 8th edn. McGraw-Hill, New York, pp 1612

    Google Scholar 

  583. Tilsner V (1981) Gerinnungsparameter bei Lebererkrankungen: Klinische Relevanz. Laboratoriumsblätter 31: 75–82

    Google Scholar 

  584. Tilsner V, Reuter H (1981) Thrombokinaseinhibitoren und ax-Antitrypsinmangel bei Leberzirrhosen als Blutungsursachen bei Aszitesinfusion. Med Welt 32: 1956–1958

    PubMed  CAS  Google Scholar 

  585. Toghill PJ, Green Sh, Ferguson R (1977) Platelet dynamics in chronic liver disease with special reference to the role of the spleen. J Clin Pathol 30: 367–371

    PubMed  CAS  Google Scholar 

  586. Townsend RR, Hilliker E, Li YT, Laine RA, Bell WR, Lee YC (1982) Carbohydrate structure of human fibrinogen. J Biol Chem 257: 9704–9710

    PubMed  CAS  Google Scholar 

  587. Troug WE, Feusner JH, Baker DL (1980) Association of hemorrhagic disease and the syndrome of persistent fetal circulation with the fetal hydantoin syndrome. J Pediatr 96: 112–114

    Google Scholar 

  588. Truell JE, Peck SD, Reiquam CW (1973) Hemangiosarcoma of the liver complicated by disseminated intravascular coagulation. Gastroenterology 65: 936–942

    PubMed  CAS  Google Scholar 

  589. Tschäppeler H, Gugler E (1968) Gerinnungsuntersuchungen bei Hepatopathien im Kindesalter. Z Kinderh 103: 349–364

    Google Scholar 

  590. Tygstrup N (1973) The prognostic value of laboratory tests in liver disease. Scand J Gastroenterol [Suppl 19] 8: 47–50

    Google Scholar 

  591. Tytgat GN, Collen D, Verstraete M (1971) Metabolism of fibrinogen in cirrhosis of the liver. J Clin Invest 50: 1690–1701

    PubMed  CAS  Google Scholar 

  592. Uehara S, Hirayama A (1977) Haemostatic studies in hepatitis. Blood Vessel 8: 127–132

    Google Scholar 

  593. Uehara S, Hirayama A (1980) Haemostasis in hepatitis-Especially aspects from endotoxemia using about chromogenic assay. Blood Vessel 11: 508–511

    Google Scholar 

  594. Uehara S, Hirayama A (1984) Studies on kallikreinkinin system in liver disease. Blood Vessel 15: 128–134

    Google Scholar 

  595. Uehara S, Hirayama A, Ishikura M (1980) Coagulation and fibrinolytic studies in hepatitis II. Blood Vessel 11: 354–358

    Google Scholar 

  596. Vermeer C, Ulrich M (1982) Vitamin K-dependent carboxylase in horse liver, spleen and kidney. Thromb Res 28: 171–178

    PubMed  CAS  Google Scholar 

  597. Verstraete M, Vermylen J, Collen D (1974) Intravascular coagulation in liver disease. Ann Rew Int Med 25: 189–198

    Google Scholar 

  598. Viallet A, Villeneuve JP (1979) Intravascular coagulation and asciticfluid infusion. Ann Intern Med 91: 318–319

    PubMed  CAS  Google Scholar 

  599. Violi F, Allessandri C, Iuliano L, Frattorali S, Gallina G, Balsano F (1984) Behaviour of FDP, plasminogen and alpha2-antiplasmin in chronic active hepatitis and liver cirrhose patients showing high FPA values. Haemostasis 14: 109

    Google Scholar 

  600. Vliet ACM van, Vliet HHDM van, Dzoljic-Danilovic G, Wilson JHP (1981) Plasma prekallikrein and endotoxemia in liver cirrhosis. Thromb Haemost 45: 65–67

    PubMed  Google Scholar 

  601. Vogel GE (1983) Early treatment with AT III in acute liver failure. Behring Institut Mitteilungen 73: 93–97

    Google Scholar 

  602. Vogel G, Bottermann P, Kuhlencordt M, Fritsche HM, Stemberger A, Blümel G, Fischer M, Schleicher P, Sommoggy S v (1979) Antithrombin III in der Behandlung von Gerinnungsstörungen beim akuten Leberversagen. Verh Dtsch Ges Inn Med 85: 477–480

    Google Scholar 

  603. Vogel GE, Bottermann P, Clarman M v, Komm Ch, Oberdorfer A (1981a) Antithrombin III treatment in acute liver failure. Thromb Haemost 46: 373 (Abstr)

    Google Scholar 

  604. Vogel GE, Tuchtenhagen S, Oberndorfer A (1981 b) Improvement of plasmatic coagulation in patients with liver disease to enable necessary diagnostic and therapeutic steps. Thromb Haemost 46: 353

    Google Scholar 

  605. Vogel GE, Komm Ch, Lorenz R, Bottermann P (1984) Das akute Leberversagenneue therapeutische Aspekte. Intensivbehandlung 9: 60–66

    Google Scholar 

  606. Volk BA, Schölmerich J, Hoppe-Seyler P, Wilms H (1983) Budd-Chiari-Syndrom: Erfolgreiche Therapie mittels peritoneo-venösem Shunt. Z Gastroenterol 21: 477

    Google Scholar 

  607. Voss B, Allam S, Ranterberg J, Ullrich K, Gieselmann V, Figura K von (1979) Primary cultures of rat hepatozytes synthesize fibronectin. Biochem Biophys Res Commun 90: 1348–1354

    PubMed  CAS  Google Scholar 

  608. Waldron-Edward D, Chan P, Skoryna SC (1971) Increased prothrombin time and metabolic changes with high serum aluminium levels following long-term exposure to Bayer-process alumina. Can Med Assoc J 105: 1297–1305

    PubMed  CAS  Google Scholar 

  609. Wallin R, Prydz H (1979) Studies on a subcellular system for Vitamin K-dependent carboxylation. Thromb Haemost 41: 529–536

    PubMed  CAS  Google Scholar 

  610. Walls WD, Losowsky MS (1971) The hemostatic defect of liver disease. Gastroenterology 60: 108–119

    PubMed  CAS  Google Scholar 

  611. Walt JA van der, Gomperts ED, Kew MC (1977) Hemostatic factors in primary hepatocellular cancer. Cancer 40: 1593–1603

    PubMed  Google Scholar 

  612. Ware S, Millward-Sadler GH (1980) Acute liver disease associated with sodium valproate. Lancet 11: 1110–1113

    Google Scholar 

  613. Watada M, Nagakawa M, Kitani T, Okajima Y, Maeda Y, Urano S, Ijichi H (1981) Identification of the AJIII synthesizing hepatocytes by immunofluorescent technique. Thromb Haemost 46: 284

    Google Scholar 

  614. Waxman S, Liu CK, Schreiber C, Helson L (1977) The clinical and physiological implications of hepatoma B12-binding proteins. Cancer Res 37: 1908–1914

    PubMed  CAS  Google Scholar 

  615. Weber E, Walter E, Harenberg J (1981) Antikoagulantien: Medikamenteninteraktion und Anwendung bei gestörter Leber-und Nierenfunktion. In: Gross R, Holtmeier HJ (Hrsg) Blutgerinnung und Fibrinolyse. Thieme, Stuttgart New York, S 35–42

    Google Scholar 

  616. Weinstein MJ, Deykin D (1978) Quantitative abnormality of an Aa chain molecular weight form in the fibrinogen of cirrhotic patients. Br J Haematol 40: 617–630

    PubMed  CAS  Google Scholar 

  617. Wenzel E, Köhler M, Hellstern P, Reiter B, Blohn G v, Dumitrescu E, Schwarze G (1983) Zur Bedeutung gerinnungsphysiologischer Untersuchungen bei Lebererkrankungen. Berichte d ÖGKC 6: 22–27

    Google Scholar 

  618. Wilkinson SP (1977) Endotoxins and liver disease. Scand J Gastroenterol 12: 385

    PubMed  CAS  Google Scholar 

  619. Winkelmann M, Borchard F, Stangel W, Grabensee B (1982) Tödlich verlaufene immunhämolytische Anämie nach Genuß des Kahlen Kremplings ( Paxillus involutus ). Dtsch Med Wochenschr 107: 1190–1194

    Google Scholar 

  620. Wold JS, Buening MK, Hanajono GK (1983) Latamoxef-associated hypoprothrombinaemia. Lancet 11: 408

    Google Scholar 

  621. Woods WG, Dehner LP, Nesbit ME, Krivit W, Coccia PF, Ramsay NKC, Kim TH, Kersey JH (1980) Fatal veno-occlusive disease of the liver following high dose chemotherapy, Irradiation and bone marrow transplantation. Am J Med 68: 285–290

    Google Scholar 

  622. Workman EF Jr, Lundblad RL (1977) The role of the liver in biosynthesis of the non-vitamin K-dependent clotting factors. Semin Thromb Haemost 4: 15–28

    CAS  Google Scholar 

  623. Yamashina A, Kaito I, Sato S, Ishi T, Motoyama S, Hatakeyama N, Kashiwabara T, Yoshida T (1978) Experimental and clinical studies on blood coagulation in fulminant hepatitis. Blood Vessel 9: 169–173

    Google Scholar 

  624. Yanofsky RA, Jackson VG, Lilly JR, Stellin G, Klingensmith WC, Hathaway WE (1984) The multiple coagulopathies of biliary atresia. Am J Hematol 16: 171–180

    PubMed  CAS  Google Scholar 

  625. Yoshimura R, Fujiyama S, Yamamoto S (1977) Clinical and experimental studies on the pathophysiology of liver diseases and intravascular coagulation. Blood Vessel 8: 133–137

    Google Scholar 

  626. Yoshimura R, Fujiyama S, Yamamoto S (1978) Significance of coagulation tests in early diagnosis of acute hepatic failure. XVII. Congr Int Soc Haematol, Paris 1978, p 795

    Google Scholar 

  627. Yoshimura R, Asai H, Harihara S, Kamata T, Monna T, Yamamoto S, Fukuda T, Maeda H (1979) Studies on haemorrhagic tendency in cirrhosis of the liver. Gastroenterol Jpn 14: 353–365

    PubMed  CAS  Google Scholar 

  628. Zellner PR, Vondung R, Chorianopoulos E (1976) Leberschädigung bei Verbrennung. In: Wannagat L (Hrsg) Toxische Leberschäden. Thieme, Stuttgart, S 160–162

    Google Scholar 

  629. Zimmerman HJ (1981) Effects of aspirin and acetaminophen on the liver. Arch Intern Med 141: 333–342

    PubMed  CAS  Google Scholar 

  630. Zimmermann R, Czygan P, Harenberg J, Kommarell B (1982) Zur Bedeutung von Antithrombin III bei der hepatischen Hämostasestörung. Inn Med 9: 270–276

    Google Scholar 

  631. Zinn W, Graham DY, Grose NP, Frankel N (1978) Circulating anticoagulant associated with chronic active hepatitis. South Med J 71: 1308–1309

    PubMed  CAS  Google Scholar 

  632. Zwierzina WD, Kunz F, Judmaier G, Mikuz G (1983) Aktue Schwangerschaftsfettleber mit Ver-brauchskoagulopathie. Dtsch Med Wochenschr 108: 703–707

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. E. Deutsch
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. I. Medizinische Klinik, Klinikum Mannheim Fakultät für Klinische Medizin Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer, D-6800, Mannheim 1, Germany

    Dieter L. Heene

  2. Orthopädische Abteilung/Krankenhaus, A-2700, Wiener Neustadt, Austria

    P. Bösch

  3. I. Medizinische Universitätsklinik, Röntgenstation, Lazarettgasse 14, A-1090, Wien, Austria

    H. Czembirek

  4. I. Medizinische Universitätsklinik, Lazarettgasse 14, A-1090, Wien, Austria

    E. Deutsch , K. Lechner  & H. Niessner ,  & 

  5. I. Medizinische Universitätsklinik, Röntgenstation 9, Lazarettgasse 14, A-1090, Wien, Austria

    J. Haller

  6. Universitäts-Kinderklinik, Klinikum der Universität, Mathildenstr. 1, D-7800, Freiburg i. Brsg., Germany

    W. Künzer  & H. Niederhoff (Akademischer Oberrat) &  (Akademischer Oberrat)

  7. School of Medicine, Department of Surgery 6-C, University Health Center, Wayne State University, 4201 St. Antoine, 48201, Detroit, MI, USA

    E. F. Mammen

  8. Klinik für Innere Medizin, Zentralkrankenhaus St. Jürgen-Str., D-2800, Bremen, Germany

    H. Rasche

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Deutsch, E. (1985). Vitamin-K-Resorptions- und Verwertungsstörungen, Hämostasedefekte bei Lebererkrankungen. In: Heene, D.L., et al. Blut und Blutkrankheiten. Handbuch der Inneren Medizin, vol 2 / 9. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70514-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70514-4_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70515-1

  • Online ISBN: 978-3-642-70514-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation